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This work focuses on the development of the muscular layers of the murine 
esophagus.  Considerable controversy surrounds the manner in which the 
muscularis externa of the esophagus develops, ever since investigators 
proposed the rare phenomenon of transdifferentiation as a mechanism for 
virtually complete replacement of smooth muscle by striated muscle that is 
observed in the murine esophagus. 
I found, using several independent levels of evidence, that transdifferentiation 
is an unlikely explanation for esophageal myogenesis.  First, by fate-mapping 
smooth muscle cells, I failed to observe expression of the fate-mapping 
marker in any esophageal striated muscle.  Second, I failed to co-localize 
expression of smooth-muscle-specific and striated-muscle-specific proteins in 
any cell undergoing differentiation into a striated muscle lineage.  Finally, 
selective deletion of a critical striated muscle transcription factor (myogenin) in 
esophageal smooth muscle cells prior to the appearance of any striated 
muscle failed to arrest subsequent esophageal striated myogenesis. 
To address prior concerns of the fate of esophageal smooth muscle, I 
examined smooth muscle morphology in transgenic mice expressing smooth-
muscle-specific eGFP, and identified 3 possible fates: (A) the incorporation of 
smooth muscle cells into the striated muscle stroma as “remnant” smooth 
muscles; (B) compaction and persistence of smooth muscle cells in the pre-
  
gastric region; and (C) occasional apoptosis of smooth muscle cells.  Using 
exhaustive co-immunolabeling methods, I demonstrated that remnant smooth 
muscle cells are indeed a previously unidentified cell population resident within 
the striated esophageal musculature. 
Finally, I examined the origin of striated muscle precursors in a series of ex 
vivo experiments.  I was able to maintain a functional esophageal phenotype 
in culture for up to 7 days, and determined that striated muscle precursors 
most likely populate the esophageal muscularis externa early in development, 
and are subsequently induced to express a myogenic program in a cranio-
caudal direction. 
Together, these findings extend the understanding of esophageal myogenesis 
and redress fundamental concepts of myogenesis, namely, 
transdifferentiation, by providing evidence of a more simple, classical 
myogenic program in this unique muscular organ.
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INTRODUCTION 
1 Esophageal Anatomy and Development 
The esophagus is a unique organ in mammals, with a seemingly limited 
function – propulsion of food and liquid from the oropharynx to the stomach via 
peristalsis, and, occasionally (or in some species, commonly), propulsion of 
gastric contents to the oropharynx (regurgitation, eructation or vomiting) via 
reverse peristalsis. 
Mammalian esophagi are all comprised of similar tissue components – 
an epithelial layer, a submucosa, a thin muscular layer of smooth muscle 
(muscularis mucosae) that is only a few cells thick, two orthogonally oriented 
muscle layers of smooth and striated muscle (muscularis externa) and the 
outer adventitial layers – consistent with the rest of the post-glossal 
gastrointestinal tract (Figure 1.1) (Achildi & Grewal 2007). 
 
 
Figure 1.1  Esophageal anatomy 
 
Despite the similar structure and common functionality across most 
species, several features make this organ interesting from both an anatomical 
2 and functional or teleological standpoint.  First, it is the only striated muscle 
organ of the gastrointestinal tract distal to the oropharynx.  As such it is the 
only striated muscle organ that is under purely autonomic neural control – 
voluntary contraction of the esophagus is not possible.  Swallowing, which is 
voluntary, is initiated within the oropharynx – the degree of swallowing, 
however, is outside the control of the swallower – once initiated, it is an all-or-
none response.  Second, it is one of few striated muscles (along with lingual 
muscles and elephantine trunk muscles) that do not have a tendino-skeletal 
attachment at one end or the other – both ends of the esophagus attach to 
non-skeletal organs, although rostrally, the longitudinal esophageal striated 
muscles merge with pharyngeal striated muscles and anchor via a membrane-
like fascia to the thyroid cartilage (Wang et al. 2007).  Third, the esophageal 
musculature comprises of both smooth and skeletal muscle portions which 
intermingle in a “transition” zone, but which, more importantly, occupy different 
proportions of the muscular layer in different species (see below). 
 
Esophageal innervation 
Innervation of the esophagus is complex.  The muscularis mucosae is 
innervated predominantly by stimulatory cholinergic vagal efferent neurons, 
with smaller numbers of adrenergic neurons (Christensen & Percy 1984, 
Kamikawa & Shimo 1979).  The response of the muscularis mucosae to 
adrenergic stimulation varies between species – in some species, contraction 
results, while in others, relaxation occurs.  Non-adrenergic-non-cholinergic 
innervation appears to be absent in the muscularis mucosae, but nitrergic and 
peptidergic neurotransmitters do inhibit vagally mediated contraction of the 
muscularis mucosae, presumably by ganglionic inhibitory actions.  
3 Additionally, endothelin mediates contraction of muscularis mucosae through 
endothelin receptors (Huang & Chang 2004, Uchida et al. 1998).  Much of the 
innervation of the muscularis mucosae is found in the submucosal plexus, also 
known as Meissner’s plexus. 
The muscularis externa has much more complex motor innervation, 
consisting of intrinsic (enteric) neurons and extrinsic (parasympathetic and 
sympathetic) neurons.  Intrinsic nitrergic neurons (nitric-oxide-mediated) and 
peptidergic neurons (VIP-mediated, substance P-mediated) have been shown 
to innervate the striated muscle of the esophageal muscularis externa, 
although the function of these intrinsic enteric neurons remains incompletely 
understood (Leander et al. 1982, Storr et al. 2000, Storr et al. 2001, Uddman 
et al. 1980).  The two muscle layers of the muscularis externa are separated 
by a neural layer – the myenteric plexus, also known as Auerbach’s plexus – 
which is composed of interneurons, enteric neurons and extrinsic neurons.  
Enteric neurons from the myenteric plexus co-innervate motor endplates of the 
striated musculature of the myenteric plexus (Wörl & Neuhuber 2005). 
Differences exist in innervation of the striated and smooth muscle segments of 
the muscularis externa, with vagal neurons from the nucleus ambiguus 
innervating the striated muscle portion, and vagal neurons from the dorsal 
motor nucleus innervating the smooth muscle portion (Diamant 1989, 
Neuhuber et al. 1998, Park & Conklin 1999).  In addition to neuronal 
innervation, the esophageal muscularis externa also contains interstitial cells 
of Cajal (ICC), which are thought to function as enteric pacemaker cells 
(Berezin et al. 1994, Takaki 2003), although recent evidence suggests that 
they may act as stretch receptors for sensory vagal neurons (Huizinga et al. 
2008, Wu et al. 2003).  Somewhat surprisingly, the ICC are not limited to the 
4 smooth muscle component of the muscularis externa, but have been found in 
the striated muscle portion as well (Burns et al. 1997, Rumessen et al. 2001, 
Wu et al. 2003). 
Sensory innervation to the esophagus is less well defined, but appears 
to consist of mechanoreceptors and thermoreceptors that function through 
sensory vagal nerves, although adrenergic sensory inputs can also be 
observed (Christensen & Percy 1984, Neuhuber et al.  1998). 
 
Esophageal muscular anatomy 
The esophageal anatomy of the muscularis externa covers the full 
spectrum of smooth and striated muscle phenotypes, ranging from a 
completely striated organ in rodents (mice, rats, guinea pigs), ruminants and 
dogs, to an organ with variably mixed cellular composition in humans, cats, 
pigs, and opossums and an exclusively smooth muscle organ in birds and 
alligators (Bremner et al. 1970, Christensen & Lund 1969, Hudson 1993, 
Jamdar & Ema 1982, Shiina et al. 2005, Uriona et al. 2005).  Several 
anatomists have recognized this anatomical diversity in the face of functional 
homogeneity and have questioned the evolutionary basis for such diversity.  It 
does not appear to depend on posture (bipedal versus quadripedal stance), 
eructation or physiological regurgitation (both dogs and ruminants have 
striated esophageal muscularis externa). 
In the conventional view the esophageal muscularis externa consists of 
two muscle layers irrespective of whether the cells are striated or smooth – an 
inner circumferential layer, and an outer longitudinal layer, separated by the 
myenteric plexus.  However, examination of data presented by Kaufmann 
(Kaufmann et al. 1968) suggests that the orientation of muscle layers in the 
5 esophagus is more complex, and often adopts an orthogonally diagonal 
orientation.  My unpublished observations of the striated muscle layers in adult 
mice support this hypothesis. 
The striated muscle cells are thought to be predominantly type IIA or 
type IIB subtypes (Hudson 1993, Shedlofsky et al. 1982, Whitmore 1982), 
although some investigators identified a novel subtype (IIoes), a finding that has 
not been subsequently confirmed (Mascarello et al. 1984).   
 
Esophageal Development 
Esophageal fetal development in the mouse (and other mammals) is a 
complex process.  In the mouse, after the formation of the gut tube from the 
endoderm at approximately embryonic day (ED) 8-8.5, the developing trachea, 
with its lung buds, separates from the esophagus by septation and elongation.  
This septation process begins around ED9.5, and is, at least in part, directed 
by sonic hedgehog (Shh) gene expression within the endoderm.  Septation is 
largely completed by ED11.5.  Mice deficient in Shh fail to separate the 
trachea and esophagus, resulting in a tracheo-esophageal fistula phenotype.  
Additionally, the esophageal endodermal-to-mesodermal Shh signaling allows 
for development of the muscular layers – mice deficient in the Shh-transduced 
transcription factor Gli2 fail to develop any esophageal smooth muscle (van 
den Brink 2007) 
The esophageal endoderm (epithelial layer) is already differentiated into 
a layer 2-to-3 cells thick by ED15 (Raymond 1991).  Initially, it comprises both 
squamous and ciliated epithelial cells, but postnatally, the ciliated (columnar) 
cells regress, while the squamous cells undergo keratinization (a process 
absent in humans) (van den Brink 2007).   
6 7 
Esophageal myogenesis 
The murine esophageal muscle forms 3 concentric layers – a thin 
mucosal layer (the muscularis mucosae), and 2 external layers (the muscularis 
externa).  The muscularis mucosae remains a smooth muscle layer throughout 
life, however, the muscularis externa initially develops as a smooth muscle 
structure that is subsequently replaced by striated muscle.  The extent to 
which this process occurs varies between species, as highlighted earlier.  The 
process by which this occurs is controversial, and not completely understood.  
Conflicting studies have argued for markedly different models of esophageal 
muscular development (Patapoutian et al. 1995, Wörl & Neuhuber 2005), and 
the conflict remains unresolved.  The controversy originated with the 
suggestion that esophageal striated myogenesis uniquely involves a process 
of transdifferentiation (see below for more details on this process), whereby 
differentiated smooth muscle cells transform into striated muscle cells 
(Patapoutian et al. 1995).  These authors suggested transdifferentiation as a 
means of esophageal myogenesis because they could not detect striated 
myogenic precursors in the esophagus, and they could not account for the fate 
of the smooth muscles, which constitute 100% of the esophageal muscularis 
externa when it first forms.  They failed to observe apoptosis of smooth muscle 
cells, and therefore hypothesized that smooth muscle cells became striated 
muscle cells.  Their observations were challenged by Zhao and Dhoot in 
several studies (Zhao & Dhoot 2000a,b,c), who claimed that myosin-light-
chain kinase (MLCK) antibody, used by Patapoutian and colleagues to identify 
smooth muscle cells, was an inappropriate marker of fetal smooth muscle 
because MLCK was not specific to smooth muscles, but was also expressed 
in developing striated muscles.  Zhao and Dhoot instead suggested that 8 
myogenic precursor cells could be identified along the esophagus as a 
separate and distinct population of cells as early as ED12.5.  At the same 
time, an ultrastructural study identified esophageal muscle cells that were 
thought to be expressing both smooth and striated muscle proteins 
simultaneously, supporting Patapoutian’s transdifferentiation hypothesis 
(Stratton et al. 2000), although the authors did not consider the possibility of 
transient developmental coexpression of heterologous proteins, which is 
known to occur in other developing organs and tissues.  Additionally, Kablar 
and colleagues argued for transdifferentiation, suggesting that Zhao and 
Dhoot’s observations of MRF expression (by in situ hybridization) were 
incorrect, and that the earliest expression of MRFs in the esophagus was at 
ED15.5, rather than ED12.5 (Kablar et al. 2000).  Reddy and Kablar followed 
up this study with another that invoked transdifferentiation as the mechanism 
of esophageal myogenesis (Reddy & Kablar 2005).  However, their data could 
be plausibly explained by conventional myogenesis.  More recently, a study by 
Wörl & Neuhuber suggested that striated muscle precursor cells are resident 
within the esophagus, although how these cells come to populate the 
superficial zone of the mesoderm is unknown (Wörl & Neuhuber 2005).  These 
investigators also identified smooth muscle apopotosis by ultrastructural 
examination (electron-microscopy), suggesting that this process accounted for 
the loss of smooth muscle cells during development of the esophageal 
muscularis externa. 
It is apparent that at least some of the discrepancies between these 
studies, such as the earliest time of onset of MRF expression, could be a 
function of different methodologies.  While Zhao and Dhoot identified Myf5 
mRNA as early as ED12.5, they only observed structural skeletal muscle 9 
protein on ED14, consistent with observations by Kablar and colleagues 
(Kablar et al. 2000, Zhao & Dhoot 2000c). 
A common feature and limitation of all these studies is the static nature 
of the investigations – all the studies involved imaging of esophageal tissue at 
different stages of development, and therefore, necessarily from different 
mice.  Thus, it is impossible to determine from these experiments if any 
particular cell changes its phenotype, as no cell can be imaged at 2 different 
points in time to demonstrate its phenotype or change in phenotype. 
Several unusual features of esophageal myogenesis and esophageal 
anatomy argue against traditional models of myogenesis.  First, as explained 
earlier, the esophagus does not have a tendino-skeletal attachment at either 
end.  Rostrally, esophageal muscles are integrated with the pharyngeal 
striated muscle, and are jointly incorporated through thin fascia into the 
laryngeal cartilage. Caudally, esophageal muscularis externa myofibers blend 
into the gastric muscularis externa.  Second, the striated esophageal 
myogenic phenotype appears relatively late in development, compared with 
appendicular, lingual and pharyngeal myogenesis.  Murine esophageal 
striated myogenesis can be first detected at ED11.5-12.5, and progresses in 
an apparent rostro-caudal direction throughout gestation, continuing 
throughout the first 2 weeks after birth, much later than striated myogenesis in 
other regions, where Myf5-expressing precursor cells are evident by day 10.  
However, once striated myogenesis begins in the esophagus, a typical striated 
myogenic program is invoked, involving the standard panel of myogenic 
regulatory factors: Myf5, MyoD, Myf6 (MRF4) and myogenin.  This myogenic 
program has been suggested to be absolutely Myf5-dependent, but 
MyoD-independent, as demonstrated by loss-of-function studies, where 10 
deletion of Myf5 resulted in loss of striated myogenesis, while loss of MyoD 
had no effect (Kablar et al. 2000).  However, it is possible that the Myf5
-/- mice 
used in this study also possessed a non-functional Myf6 gene, as the targeting 
construct was similar to the Myf5
nLacZ construct used by other investigators 
(Kassar-Duchossoy et al 2004).  These investigators showed that the integrity 
of Myf6 was dependent on the type of targeting construct used to inactivate 
Myf5.  However, they did not investigate esophageal myogenesis in any of the 
three Myf5
-/- lines they created to determine if esophageal striated myogenesis 
was in fact dependent on expression of Myf5 or whether Myf6 inactivation was 
responsible for the myogenic failure that Kablar et al observed. 
Defects in esophageal myogenesis have been occasionally, and 
somewhat randomly, observed in various phenotyping experiments of 
transgenic mice, or mice with specific genetic loss of function (knockout mice).  
Randelia and colleagues first described esophageal myogenic dysplasia in 
ICRC-HiCri mice (an inbred strain that developed various neoplasms and was 
maintained at the Cancer Research Institute) that had spontaneously 
developed megaesophagus, which was shown to be a recessive genetic trait 
(Randelia & Lalitha 1988,Randelia et al. 1990).  These mice failed to complete 
striated myogenesis, with the caudal portion of the esophagus retaining its 
smooth muscle phenotype.  Subsequently, Wang and colleagues identified an 
esophageal dysplasia in mice with a deleted frizzled-4 gene (Wang et al. 
2001).  These mice failed to undergo striated myogenesis, presumably due to 
a loss of pro-myogenic Wnt signaling, although other somitic myogenesis that 
is dependent on Wnt signaling proceeded uninterrupted.  This suggests that 
frizzled-4 may be the Wnt receptor expressed in esophageal striated myogenic 
progenitor cells but not in other somitic progenitor cells. 11 
Unpublished data from our laboratory identified esophageal dysplasia in 
a colony of inbred RyR3
-/- mice (mice in which the Ryanodine Receptor 3 gene 
had been deleted).  These mice had a partial failure of striated myogenesis 
similar to that seen by Randelia and colleagues and developed 
megaesophagus (Figure 1.2).  However, after development of a congenic 
RyR3
-/- strain, the frequency of the dysplasia decreased to 25% of offspring, 
despite carrying two mutant RyR3 alleles.  This suggested that the esophageal 
defect was a recessive characteristic, associated with a gene other than 
RyR3, or that RyR3 effects were modified by other, unidentified, genes. 
 
 
Figure 1.2  Esophageal dysplasia in RyR3
-/- mice.  Immunofluorescent 
staining of smooth muscle in normal and RyR3
-/- mice reveals a myodysplasia, 
with failure of striated myogenesis in RyR3
-/- mice arising midway along the 
esophagus. 
 
Sumiyoshi et al (Sumiyoshi et al. 2004) showed that a lack of Collagen 
XIXα1 in mice arrested the myogenic transformatory process at birth, 12 
suggesting a role for extracellular matrix in normal esophageal myogenesis.  
In a study examining the effect of Tbx1 and FGF8 in cardiac development, 
researchers observed what was considered a defect of esophageal smooth 
muscle development in FGF8-deficient mice (Brown et al. 2004).  However, 
the examination (performed on new-born mice) did not specify the region of 
esophagus being examined; therefore it is possible that the authors 
unknowingly sectioned esophagus that had already undergone striated 
myogenesis. 
It is interesting to note that most other studies of factors regulating 
cranial or somitic myogenesis have consistently ignored the effects on 
esophageal myogenesis.  Kassar-Duchossoy et al (Kassar-Duchossoy et al. 
2004) examined several Myf5
-/- models, but ignored the esophagus.  
Vasyutina and colleagues (Vasyutina et al. 2005) examined myogenesis using 
an Lbx1
GFP mouse, which labels all hypaxial musculature, but ignored the 
esophagus.  However, in a previous study, Gross and colleagues, using a 
mouse with an inactivated Lbx1 gene, demonstrated that Lbx1 deficiency did 
not affect development of the tongue and larynx, despite the fact that the 
myogenic progenitor cells that form these muscles express Lbx1 during 
migration from the occipital somites (Gross et al. 2000).  Like Vasyutina et al, 
they failed to examine the esophagus.  Nevertheless, if esophageal striated 
muscle is of somitic origin, it is unlikely to require Lbx1 for expression.  
Burgess and colleagues (Burgess et al. 1996) inactivated Paraxis, a gene that 
is instrumental in somite morphogenesis, but did not examine the esophagus.  
However, axial and appendicular musculature, while abnormal in these mice, 
was present.  Takahashi and colleagues more recently examined 
Mesp2/Paraxis double-null mice, but also ignored esophageal myogenesis 13 
(Takahashi et al. 2007).  Similarly, I could find no studies examining 
esophageal myogenesis in the spontaneous Pax3 mutant Splotch mouse.  
However, Pax3 null mice appear to have normal esophageal myogenesis 
(Tajbakhsh S, personal communication 2003), which might suggest that 
esophageal myogenic progenitor cells are not of somitic origin. 
The paucity of esophageal evaluation in studies of cranial myogenic 
programs is equally apparent.  Kelly et al examined Tbx1 in cranial muscle 
development but failed to examine the esophagus (Kelly et al. 2004).  A study 
by Lu et al examining the role of Msc (MyoR) and Tcf21(capsulin) in cranial 
myogenesis also ignored the esophagus (Lu et al. 2002).  It is intriguing to 
speculate that esophageal myogenic progenitor cells originate in the 
unsegmented cranial paraxial, or possibly even prechordal mesoderms, but 
evidence is lacking. 
Thus, the exact source(s) of esophageal striated myofibers remains 
mostly undetermined. 
 
Striated Myogenesis 
Features of axial, appendicular and cranial myogenesis may help 
identify the process of esophageal myogenesis.  It is interesting to note that 
virtually no review of striated myogenesis discusses the esophagus.  
Additionally, most studies of mammalian myogenic lineages (cranial paraxial 
mesoderm versus somitic paraxial mesoderm) ignore esophageal 
myogenesis. 
 Head and body muscles have different embryonic origins 
Two distinct and separate myogenic programs control the development 
of striated musculature in mammals. The muscles of the body develop from 
the dermomyotome, a collection of cells found in paraxial mesodermal somites 
that lie beside the neural tube from the occipital region to the tail.  Several 
comprehensive reviews detail the process of somitically-derived axial and 
appendicular myogenesis (Biressi et al. 2007, Bryson-Richardson & Currie 
2008, Buckingham 2006, Grefte et al. 2007, Shih et al. 2007).  Most skeletal 
muscles in the head originate in the cranial paraxial and splanchnic 
mesoderms.  Myogenic primordia expand into the branchial (pharyngeal) 
arches, where they undergo final lineage commitment and subsequently move 
peripherally to their various cranio-facial locations.  The exception to this are 
the muscles of the tongue and neck (non-masticatory, non-ocular muscles), 
which originate from somites, and most of the extraocular muscles, which 
arise from myogenic domains located originally in both paraxial and prechordal 
mesoderms (Tzahor 2009).  Muscles of the pharynx, unlike the hypoglossal 
muscles, originate from the cranial paraxial mesoderm.  Cranial myogenesis is 
less extensively reviewed than axial myogenesis (Grifone & Kelly 2007, Noden 
& Francis-West 2006, Tzahor 2009). 
Three myogenic phases or waves are described in somitic myogenesis: 
embryonic, fetal and post-natal; also known as primary, secondary and tertiary 
myogenic waves.  Primary myogenesis involves early formation of myotomal 
myoblasts and mononucleated myocytes.  These Myf5/Myf6-expressing cells 
(see below for further details of molecular sequences in myogenesis) 
delaminate from the dermomyotome to form the early embryonic myotome, 
which will later give rise to all axial, appendicular and body wall musculature.  
14 However, within this population of cells are a subset of myogenic precursor 
cells that express Pax3 and Pax7, which do not undergo rapid differentiation 
into myoblasts, but are maintained as a population of proliferating myogenic 
precursors.  These myogenic precursors provide the bulk of myoblasts in the 
fetal wave of myogenesis, when axial and appendicular hyperplasia is 
markedly accelerated. 
Simultaneously with the formation of the mature myotome, myogenic 
precursors delaminate from the hypaxial lip of the dermomyotome of certain 
somites, and migrate to appendicular locations – these precursors form the 
limb muscles, as well as the tongue and neck muscles. 
During the later, fetal, phase of development, Pax3/Pax7-expressing 
progenitor cells, which have migrated with the primary myoblast pool to their 
ultimate location (e.g., limbs, diaphragm, etc.), begin to proliferate and expand 
the resident myoblast population.  This expansion is regulated by expression 
of Tgfβ and other antagonists of bone morphogenic protein (BMP), which acts 
to promote myoblast proliferation. 
Finally, a third, post-natal, phase of myogenesis can be observed, both 
post-natally, as part of normal myogenesis, and subsequently during muscle 
regeneration following muscle injury.  This involves the differentiation of 
satellite cells (adult striated muscle stem cells), which populate muscles, and 
reside within muscle bundles (under the basal lamina of myocytes) as 
undifferentiated, Pax7-expressing mononuclear cells.  Following muscle injury, 
these cells are induced to undergo myodifferentiation and proliferate as 
myoblasts to ultimately form myotubes, replacing damaged and killed 
myotubes. 
15 The muscles of the head originate in prechordal, paraxial, and lateral 
mesoderms.  Cells from the prechordal mesoderm stream laterally and 
contribute to those extra-ocular muscles innervated by the oculomotor (IIIrd) 
cranial nerve.  Paraxial mesoderm, which in the head fails to form epithelial 
somites, forms the other extra-ocular muscles and all proximal pharyngeal 
(branchial) arch muscles (Evans and Noden 2006).  Recent studies in avian 
and mammalian embryos revealed an islet-1-positive population of cells 
located adjacent to paraxial mesoderm, in a location analogous to lateral 
mesoderm, that contributes to the distal branchial muscles, and also extrinsic 
laryngeal muscles (Nathan et al. 2008).  These authors reported that the 
esophagus is also labeled in their islet-1-LacZ transgenic mice, but did not 
show the data or discuss which cell populations are labeled (and did not imply 
that muscle was labeled).  Interestingly, this islet-1-expressing cell population 
also contains cardiac myocytes that contribute to the outflow tract of the heart. 
 
Head and body muscles have different myogenic programs 
Not only does the origin of striated muscle differ, but the genetic and 
molecular pathways involved in myogenesis of these two groups of muscles 
also differs. 
Somitic myogenesis is induced by expression of Pax3 and Wnt in the 
dermomyotome.  Additionally c-Met is thought to play a role in directing 
migration of somite-derived appendicular myogenic precursors, while Notch 
signaling prevents onset of commitment and maintains a progenitor state 
(Vasyutina et al. 2007).  Recently, other early embryonic genes, such as Six1, 
Six4, Eya1 and Eya2 and SRF (Serum Response Factor) have been shown to 
play a role in myogenesis, in part by affecting Pax3 expression and function 
16 (Buckingham 2006).  Under the influence of Pax3 and N-cadherin, myogenic 
progenitor cells delaminate from the dermomyotome and induce the classically 
recognized myogenic pathway involving activation of a series of transcription 
factors, known as myogenic regulatory factors, in a particular sequence.  
In the classic model of myogenesis, the basic helix-loop-helix MRFs, Myf5 
and MyoD, are activated first, with Myf5 slightly preceding and inducing MyoD 
activation.  These two MRFs have been considered the early “commitment” 
MRFs – cells expressing these MRFs are committed to becoming myoblasts. 
MyoD and Myf5 then induce expression of the differentiating MRFs, Myf6 
(MRF4) and myogenin (myog), which in turn initiate expression of muscle-
specific functional proteins and downstream transcriptional regulators, 
such as Mef2 (Figure 1.3). 
 
 
Figure 1.3  Classic Striated Myogenic Program.  Pax3, under the influence 
of Wnt signaling from the neural tube and ectoderm, induces expression of the 
myogenic determination (commitment) basic-helix-loop-helix transcription 
factors, Myf5 and MyoD in myogenic progenitor cells.  Additionally, Myf5 
activates MyoD expression.  Together, these factors induce expression of 
Myf6 and Myogenin, which trigger myodifferentiation into myoblasts, with 
subsequent expression of Mef2 and sarcomeric proteins. 
 
17 This classical myogenic pathway has undergone considerable evolution 
since it was initially described and proposed.  Complex studies of the roles of 
Myf5, MyoD and Myf6 revealed a substantially more complex interaction of 
these MRFs than had been previously thought.  First, investigators identified 
largely redundant, but not completely interchangeable roles for Myf5 and 
MyoD.  Deletion of either of these MRFs resulted in marginally altered 
myogenesis, and an essentially normal muscle phenotype (Braun et al. 1992, 
Rudnicki et al. 1992).  Deletion of both of these MRFs resulted in complete 
absence of axial and appendicular musculature (Rudnicki et al. 1993).  
However, further studies revealed that Myf6 shares the same locus as Myf5 (it 
resides within the enhancer/promoter region of Myf5) and Myf5 deletion in the 
early experiments also inactivated Myf6.  Subsequent experiments that 
inactivated Myf5, but preserved Myf6 function, revealed that Myf6 could induce 
axial, but not appendicular myogenesis in the absence of both Myf5 and MyoD 
(Kassar-Duchossoy et al. 2004).  Thus, the role of Myf6 appears to be more 
complex than originally thought – it functions in both commitment and 
differentiation.   
Additionally, recent studies have suggested that rather than having 
redundant roles in myogenic commitment, Myf5 and MyoD regulate initially 
separate populations of myogenic precursors (Haldar et al. 2008).  Myogenin, 
while considered essential for myodifferentiation prenatally (myog
-/- mice fail to 
develop muscle), is not essential for the third (postnatal) wave of myogenesis 
(temporally conditional myog
-/- mice have essentially normal muscles), even 
though it is essential for differentiation of Pax7-positive satellite cells that 
contribute to the third myogenic wave (Knapp et al. 2006).  Thus, the exact 
role of myogenin is not completely defined (Figure 1.4). 
18  
Figure 1.4  Striated myogenic program.  Epaxial myotome expresses a 
slightly different myogenic program from hypaxial myotome.  Additionally, 
Lbx1-positive myogenic progenitors separate from the hypaxial lip and migrate 
to appendicular sites. 
Somitically-derived myogenic precursors migrating peripherally into the 
body wall and appendicular regions activate additional molecular programs to 
those expressed in axial muscles.  Translocating myogenic cells express Lbx1 
and CXCR4 during the migration process and are regulated by Wnt signaling 
(Vasyutina et al 2005). (Figure 1.4) 
The muscles of the head express a fundamentally different myogenic 
program (Figure 1.5).  First, Wnt signaling, which initiates somitic myogenesis, 
inhibits myogenesis in head muscle progenitor cells.  Upstream regulators of 
MRF expression in head muscle progenitor cells also differ.  Through loss-of-
function experiments, transcription factors such as Tbx1, Pitx2, Msc (MyoR) 
and Tcf21 (Capsulin) have been demonstrated to regulate cranial myogenesis, 
without affecting axial/somitic myogenesis, despite the observation that 
several of these factors [Pitx2, Msc] are expressed in somitic subdomains or 
after somitic myodifferentiation (Dong et al. 2006, Kelly et al. 2004, Lu et al. 
2002).  Specifically, lack of Msc and Tcf21 inhibits myogenesis in the proximal 
19 part of the first pharyngeal arch, resulting in altered masticatory muscle 
development (Lu et al. 2002).   
 
Figure 1.5  Cranial myogenic program.  Pharyngeal arch (PA1 & PA2) and 
extraocular (EO) myogenesis is regulated differently from somitic myogenesis 
and differs even between cranial myogenic loci.  Additionally, less is known 
about specific upstream regulators and regulatory interactions of Myf5 and 
MyoD. 
 
Deletion of Tbx1 results in patchy and sporadic myogenesis of 
masticatory muscles by altering myogenesis most notably in the 1
st arch (Kelly 
et al. 2004). However, since Tbx1 is also expressed in tissues adjacent to 
these muscles, it is not clear from knockout studies whether this negative 
effect is direct or indirect.  Similar alterations in myogenesis are observed with 
Pitx2 mutants, which have reduced Tbx1, Mcf, Tcf21, and, consequently, Myf5 
activation in the pharyngeal arches and periocular tissues (Dong et al. 2006, 
Shih et al. 2008).  Deficiencies in these transcription factors manifest most 
severely in the 1
st arch and oblique extraocular muscles, suggesting that 
20 other, as yet undiscovered, myogenic regulators affect branchiomeric and 
extra-ocular myogenesis.  For example, the role of Tlx1, a homeobox-
encoding transcription factor expressed in arch-derived myogenic precursors, 
but not somitic precursors, is not defined (Grifone & Kelly 2007). 
On the other hand, Pax3 is not expressed in head muscle progenitor 
cells, and Pax3
-/-::Myf5
-/- mice develop normal head muscles, while lacking 
body muscles (Tajbakhsh et al. 1997).  This is presumably due to the 
independent myogenic rescuing effects of MyoD in head muscles, but not in 
body muscles, where MyoD expression is Pax3-dependent.  Further 
differences in myogenic programs are evidenced by different requirements for 
Myf6.  Mice deficient in Myf5 and MyoD, but with a functional Myf6 gene, 
develop axial, somitically derived muscles (but not limb muscles) (Kassar-
Duchossoy et al. 2004).  However, head muscles fail to form, suggesting that 
Myf6 is unable to rescue head myogenesis in the absence of Myf5 and MyoD. 
As stated earlier, which of these early myogenic programs, if any, is 
expressed in the developing esophageal muscularis externa, is currently 
unknown. 
 
Transdifferentiation and Cellular Plasticity 
In 1995, Patapoutian and colleagues suggested that esophageal 
striated myogenesis occurs through a process known as transdifferentiation, 
rather than originating from distinct progenitor subpopulations.  
Transdifferentiation describes the transformation of one differentiated (or 
committed) cell type into another (Patapoutian et al. 1995).  Recently, the term 
has been used less discriminantly, to describe plasticity of stem cells, namely, 
the directed or induced differentiation of stem cells into particular cellular 
21 phenotypes.  However, since stem cells are not necessarily committed to a 
particular lineage, but can maintain a certain degree of pluripotency even if 
apparently lineage-restricted, the term is inappropriate in this context.  To that 
end, Eguchi and Kodama suggested that 2 criteria should be met to use the 
term “transdifferentiation” (Eguchi & Kodama 1993): first, that the 
differentiated state before and after transdifferentiation can be reliably 
described and distinguished and second, that a direct ancestor-
descendent relationship between cells before and after the phenotype 
switch can be demonstrated. 
Transdifferentiation was first coined as a term for this process by 
Eguchi and Okada in 1973 (Eguchi & Okada 1973), but interest in this process 
grew in the 1990s with the potential for stem-cell directed therapies.  
Understanding transdifferentiation could allow scientists to use abundant cell 
types to replace injured or diseased cell types by inducing them to 
transdifferentiate into replacement cells.  For example, hepatocytes could be 
induced to transdifferentiate into pancreatic cells in the treatment of diabetes 
mellitus. 
Two models of transdifferentiation are currently considered possible, 
and both may occur in different situations.  The first model requires a 
differentiated cell to de-differentiate into a primordial cell that is then induced 
to re-differentiate into the new phenotype.  In the second model the 
differentiated cell simply changes phenotype without an intermediary step 
(Burke & Tosh 2005) (Figure 1.6). 
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Figure 1.6  Models of transdifferentiation.  Transdifferentiation is thought to 
occur either by dedifferentiation into an intermediate primordial cell, or directly 
without involvement of a de-differentiation step. 
 
Several examples of transdifferentiation are currently accepted as likely 
events.  Many of these appear to be restricted to in vitro manipulation of 
committed or differentiated cells.  Xie et al transdifferentiated B lymphocytes 
into macrophages by adding specific transcription factors (C-EBPα and C-
EBP-β) (Xie et al. 2004).  The authors provided compelling evidence for 
transdifferentiation and proposed a model by which such a process might 
occur: they found that these transcription factors suppressed B lymphocyte-
specific gene expression while simultaneously inducing macrophage-specific 
gene expression.  Importantly, however, the B lymphocytes were committed 
progenitor cells, rather than differentiated mature B lymphocytes.  
Nevertheless, the process of B lymphocyte-to-macrophage transdifferentiation 
was induced both in vivo and in vitro.  Heyworth and colleagues showed 
similar plasticity of lineage-restricted hemopoietic progenitor cells in vitro by 
modulating transcription factors in these cell lines (Heyworth et al. 2002). 
23 In vitro pancreatic cell-to-hepatocyte transdifferentiation has been 
demonstrated by several groups of investigators (Shen et al. 2000, Tosh et al. 
2002).  These investigators, like Xie et al, found that C-EBPα and C-EBPβ 
were responsible for this phenotype switching (Westmacott et al. 2006).  
Likewise, Roach and colleagues induced a phenotype change in embryonic 
bone cultures where hypertrophic chondrocytes transdifferentiated into 
osteoblasts (Roach 1992, Roach et al. 1995). 
Transdifferentiation of muscle cells has also been observed, or 
postulated.  Cultured G8 myoblasts have been transdifferentiated into 
adipocytes in vitro by expression of C-EBPα and (PPAR)-γ (Hu et al. 1995), 
while another myoblast cell line C2C12 was transdifferentiated into adipocytes 
by inhibiting Wnt signaling (Ross et al. 2000).  More recently, these events 
have been explained by demonstrating the common origin of brown fat cells 
and skeletal muscle cells from Myf5-expressing progenitors (Seale et al 2008).  
Bobryshev suggested that chondrocytes found in atherosclerotic plaques 
transdifferentiated from smooth muscle cells (Bobryshev 2005), although 
these findings have not been confirmed by other investigators.  Several 
investigators have demonstrated the ability of striated muscles in some 
jellyfish (Podocoryne carnea) to transdifferentiate into smooth muscle and 
sensory nerve cells via a de-differentiated intermediary smooth muscle stem 
cell when manipulated in cell culture (Alder & Schmid 1987, Galle et al. 2005, 
Schmid & Alder 1984, Schmid et al.1993).  Weintraub showed MyoD 
expression forces many cell types to become striated muscle cells (Weintraub 
et al. 1989), although the relevance of this to in vivo processes is uncertain.  
Finally, multiple investigators have demonstrated a transdifferentiation of 
striated muscle in urodele amphibian limb regeneration (see below). 
24 Transdifferentiation in situ has also been proposed, although evidence 
of this event is limited.  Additionally, virtually all putative observations of 
transdifferentiation have been restricted to regenerative processes, rather than 
normal development, and most often observed in non-mammalian species.  
The original observations of transdifferentiation were made by Wolff at the turn 
of the last century, although the event was not termed “transdifferentiation” at 
that time.  Wolff noted that new lens tissue in amphibians formed from 
pigmented iridal epithelial cells after enucleation.  Hans Spemann made 
similar observations and experimented with lens regeneration at around the 
same time (Spemann 1901).  These observations were extended to other 
species (chickens, humans) (Eguchi & Okada1973, Eguchi 1988), and 
subsequently shown to be commonly inducible in vitro events with cells of 
diencephalic origin (possibly associated with the formation of the “parietal 
eye”) (Jurić-Lekić et al. 1991).   
The other, well-recognized, model of natural transdifferentiation is that 
of striated muscle cells and other cells during limb regeneration in urodele 
amphibians.  This phenomenon has been long recognized (Thornton 1938), 
and intensively investigated (Echeverri et al. 2001, Hay 1961, Kumar et al. 
2000, Lo et al. 1993, Simon et al. 1995, Tanaka et al. 1997, Velloso et al. 
2000, Velloso et al. 2001).  The commonly held view in newt limb regeneration 
is that myocytes enter the cell cycle, dedifferentiate into pluripotent 
mononucleated blastema cells, and then differentiate into various tissues.  
This cell-cycle entry and dedifferentiation is mediated by a humoral factor 
found both in serum and in blastema extracts which is thought to activate Msx-
1, a homeobox transcription factor that can induce dedifferentiation of 
myotubes and maintain a dedifferentiated state (Odelberg et al. 2000).  
25 Echeverri and Tanaka additionally demonstrated transdifferentiation of 
ectodermally derived neural stem cells into mesodermal tissues – muscle and 
chondrocytes – in axolotls undergoing tail regeneration after amputation 
(Echeverri & Tanaka 2002).  However, Gargioli and Slack showed a lack of 
transdifferentiation in tail regeneration in Xenopus tadpoles, and argued that a 
more traditional “healing” response was invoked (Gargioli & Slack 2004).  
Thus, the field of muscle transdifferentiation still remains incompletely defined. 
In 1995, Patapoutian and colleagues published a paper claiming the 
first instance of transdifferentiation in a mammal as part of the normal 
development process, rather than as a response to regeneration or injury 
(Patapoutian et al. 1995).  Specifically, these authors proposed that the 
smooth muscle cells in the fetal murine esophagus transdifferentiated into 
striated muscle during development, resulting in the final striated phenotype 
observed in adult mice.  By co-immunostaining for smooth-muscle and 
striated-muscle markers, they showed co-expression in cells they considered 
to be in the process of transdifferentiation.  This observation excluded the 
dedifferentiation/redifferentiation model as a possible mechanism, and even 
more astoundingly, argued for transdifferentiation of cells that are only 
primitively related embryologically (both cell types do originate from the 
dermomyotome and express Pax3 early in their progenitor stage), a notion 
that flies in the face of accepted transdifferentiation theory (Tosh & Slack 
2002).  These results were variably supported (Kablar et al. 2000, Reddy & 
Kablar 2004, Stratton et al. 2000) or challenged (Zhao & Dhoot 2000a,2000b, 
2000c, Wörl & Neuhuber 2005). 
 
26 Hypothesis 
The literature reviewed and summarized above reveals several gaps in 
the understanding of esophageal myogenesis and raises several questions.  
First, can transdifferentiation be more conclusively demonstrated as a 
mechanism for striated myogenesis in the murine esophagus?  Second, if 
transdifferentiation does not occur, what is the fate of the smooth muscle 
population that constitutes 100% of the muscle cell type in early esophageal 
development?  And third, if striated muscle cells do not arise by 
transdifferentiation, where do they originate? 
The following chapters detail several studies of esophageal myogenesis 
that aim to answer some of these questions. Specifically, I hypothesized that 
murine esophageal striated myogenesis does not occur by transdifferentiation 
of esophageal smooth muscle cells, and that fate-mapping and conditional 
gene inactivation experiments would confirm this.  Further, I hypothesized that 
the smooth muscle cell population did not require marked apoptosis or 
transdifferentiation to explain its apparent disappearance, but that growth and 
organ remodeling could account for the smooth muscle cells.  Finally, I 
hypothesized that striated muscle precursors were resident within the 
muscularis externa prior to their initial expression of myogenic regulatory 
factors, and that the onset of myogenesis could be demonstrated ex-vivo. 
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40 Introduction, Results and Discussion 
Transdifferentiation is the conversion of cells from one differentiated 
phenotype to another (Tosh and Slack, 2002), a process that implies 
substantial cellular plasticity and could allow regeneration or repair of tissues 
or organs with cells committed to dissimilar lineages. The developmental 
program of the mouse esophagus, in which the esophageal musculature is 
converted from smooth to skeletal muscle, is perhaps the most commonly 
cited example of transdifferentiation during normal mammalian development 
(Patapoutian et al., 1995). The external muscle layer of the fetal mouse 
esophagus initially develops as smooth muscle and is gradually and almost 
completely converted to skeletal muscle by the second week of postnatal life. 
Here we show conclusively that skeletal myocytes arise from a distinct 
lineage, rather than through the transdifferentiation of smooth muscle cells. 
To permanently lineage-map smooth muscle cells we crossed 
transgenic mice expressing Cre recombinase and eGFP under control of the 
smooth muscle myosin heavy chain promoter (Xin et al., 2002) with R26R 
LacZ reporter mice. In these double transgenic mice, all differentiated smooth 
muscle cells express eGFP, whereas cells that were of smooth muscle 
phenotype at any point in development constitutively express β-galactosidase 
through Cre recombinase-mediated excision of an inhibitory cassette at the 
ROSA26 locus.  
In 15-day post-conception (dpc) fetuses, eGFP expression and X-gal 
staining marked the muscle layers along the entire esophagus, identifying 
them as being predominately composed of smooth muscle, and demonstrating 
tissue-specific activation of the LacZ gene (Figure 2.1, left panels).
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Figure 2.1  Lineage mapping of murine esophageal smooth muscle. a. 
eGFP fluorescence of ED 15 (left), PN 1 (middle), and PN 21 (right) transgenic 
mice, showing cranio-caudal regression of smooth muscle in the esophagus 
with maturation.  b: LacZ expression at same stages indicates parallel 
regression of smooth muscle, fate-mapped cells. 
 
If esophageal smooth muscle transdifferentiated into striated muscle, 
this X-gal staining pattern would be anticipated to be retained in spite of a 
cranio-caudal regression of eGFP fluorescence associated with the regression 
of smooth muscle during development. Conversely, replacement of smooth 
muscle through skeletal myogenesis from non-smooth muscle cells would 
show parallel regression of X-gal staining and eGFP fluorescence in the 
muscularis externa, but not the muscularis mucosae (which remains smooth 
muscle throughout adult life). 
42 We found that both the X-gal staining pattern and eGFP expression in 
the external muscle layers regressed cranio-caudally as the esophagus 
matured. In 1-day-old mice (at which time the external esophageal muscle is 
approximately 30–50% transformed from smooth to striated), only the caudal 
two-thirds of the esophagus showed X-gal staining, completely concordant 
with eGFP expression (Figure 2.1, middle panels). At 21 days (when the 
murine esophagus is fully developed), only the terminal esophagus showed X-
gal staining, identical to eGFP fluorescence (Figure 2.1, right panels).  
 
 
Figure 2.2  LacZ expression is limited to esophageal smooth muscle 
cells. Above, LacZ expression in section of caudal esophagus showing 
staining of muscularis externa at PN 1 (left, filled arrow) and loss of smooth 
muscle fate-mapped cells in this layer at PN 21 (right). Smooth muscle in the 
muscularis mucosae (open arrow) is stained. Below, Inset showing LacZ-
negative, skeletal myocytes in muscularis externa (filled arrow), as well as 
LacZ-positive cells in muscularis mucosae (open arrow), at PN 21. Scale bar = 
50 μm. 
 
43 Histologic sections demonstrated that skeletal fibers were completely 
free of X-gal staining, whereas smooth muscle in the muscularis mucosae 
exhibited X-gal staining in the same sections (Figure 2.1b and Figure 2.2).  To 
exclude the possibility that the failure of any skeletal fibers to express LacZ 
results from the differentiation of skeletal myocytes from a subpopulation of 
smooth muscle cells that do not express the transgene, we examined eGFP 
and smooth muscle α-actin staining in rostral esophageal sections from 15 dpc 
embryos. eGFP and smooth muscle α-actin expression in the muscularis 
externa were concordant, with cells expressing both proteins in two layers, 
separated by a single cell layer of nonsmooth muscle cells (Figure 2.3). 
 
 
Figure 2.3  Smooth muscle α-actin (left) and eGFP (right) antibody 
staining of the esophageal muscularis externa of 15 day-post-conception 
fetuses. Both layers of the muscularis externa are stained with each antibody. 
A population of nonstaining cells is present between the two layers. 
 
Thus, the coordinate regression of eGFP and X-gal-positive cells seen 
throughout the esophagus in the fetus to the most caudal esophagus in 
mature mice is definitive evidence that striated esophageal myocytes do not 
transdifferentiate from smooth muscle cells, but arise through skeletal 
myogenesis of a separate pool of skeletal precursor cells (Zhao and Dhoot, 
2000). The evidence against transdifferentiation is particularly compelling 
given the expression of LacZ along the complete length of the embryonic 
44 esophagus, indicating Cre recombinase activity sufficient to produce 
recombination in all embryonic smooth muscle. 
These results highlight the unique myogenic program in the mammalian 
esophagus and, more importantly, place additional constraints on the notion of 
transdifferentiation during normal development in mammals and the plasticity 
of distinct muscle lineages. 
 
Materials and Methods 
R26R LacZ reporter mice were crossed with male 
smMHC/Cre/IRES/eGFP (Xin et al., 2002) mice from a single line (SMCG2). 
ED (embryonic day) 15 embryos and 1- and 21-day postnatal mice were 
analyzed. Embryos and day-old mice were dissected to expose the esophagus 
and stomach by removing all other viscera. In postnatal day (PN) 21 mice the 
esophagus and stomach were removed for fluorescence imaging, fixation, and 
staining. eGFP fluorescence in mice or tissues was visualized by 
epifluorescence microscopy and tissues were stained for β-galactosidase 
activity using standard methods. Briefly, mice or tissues were fixed for 20 
minutes to 1 hour in 4% formaldehyde at 4ºC, rinsed once in PBS, then 
permeabilized in permeabilization buffer (100 mM sodium phosphate (pH 7.3), 
2 mM magnesium chloride, 0.01% sodium deoxycholate, 0.02% NP-40 (by 
volume)), once at 4ºC and twice at room temperature for 30 minutes, and 
stained in staining solution (permeabilization buffer plus: 5 mM potassium 
ferricyanide, 5 mM potassium ferrocyanide, 1mg/mL X-gal) for 18 hours at 
room temperature in the dark. 
X-gal-stained tissues from day-old and 21-day old mice were processed 
by standard histological methods, with the exception that the pre-embedding 
45 infusion of the dehydrated tissues was performed with an isopropanol-paraffin 
solution rather than xylene. Sections were stained with eosin only. 
Smooth-muscle α-actin and eGFP immunohistochemistry was 
performed on formalin-fixed, paraffin-embedded embryos, processed 
identically to tissues described above. Sections were counterstained with 
hematoxylin. 
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48 Abstract 
Following initial patterning as differentiated smooth muscle cells, the 
muscularis externa of the murine esophagus is replaced by skeletal muscle, 
but the mechanism underlying this process is controversial. The hypothesis 
that committed smooth muscle cells transdifferentiate into striated muscle is 
not consistent with fate mapping studies. Similarly, apoptosis does not fully 
explain the process. Using immunohistochemical techniques and transgenic 
mice that express eGFP and Cre recombinase exclusively in smooth muscle, 
we have identified a population of remnant smooth muscle cells that persist 
throughout the developing and mature murine esophagus. These cells display 
an atypical phenotype, are not associated with microvasculature, but are often 
apposed to c-Kit positive, interstitial cells of Cajal. The absolute length of the 
smooth muscle component of the developing esophagus remains constant 
during a period when total esophageal length increases 4-fold, resulting in a 
small maintained distal segment of smooth muscle. Esophageal smooth 
muscle cells fail to express myogenin during development, and striated muscle 
cell precursors expressing myogenin fail to express specific smooth muscle 
cell markers, indicating that they did not transdifferentiate from smooth muscle 
cells. Moreover, smooth muscle-specific myogenin inactivation has no effect 
on esophageal skeletal myogenesis.  
Taken together, our results provide an alternative hypothesis regarding 
the fate of smooth muscle cells in the developing murine esophagus, which 
does not invoke apoptosis or transdifferentiation.
49 Introduction 
The murine esophagus begins development at approximately 
embryonic day 11.5, as a tube ensheathed by three layers of smooth muscle 
cells—the muscularis interna (muscularis mucosae), and two layers of the 
muscularis externa. Over a 3-week period (until about postnatal day 14), the 
smooth muscle of the muscularis externa is progressively replaced by striated 
muscle in a cranio-caudal direction. The mature murine esophagus has a 
small smooth muscle segment just cranial to the lower esophageal sphincter, 
but striated muscle composes >95% of the muscularis externa. 
The mechanism underlying the process of muscular substitution is 
controversial. Initial studies of murine esophageal development suggested that 
committed smooth muscle cells transdifferentiated into striated muscle cells 
(Patapoutian et al. 1995; Kablar et al. 2000; Stratton et al. 2000), however, 
several lines of evidence raise fundamental doubts with respect to the 
transdifferentiation hypothesis of the origin of esophageal skeletal muscle. 
First, esophageal striated muscle cells fail to develop in mice lacking Myf5 and 
MyoD myogenic regulatory factors (Kablar et al. 2000; Reddy and Kablar 
2004), indicating that if transdifferentiation occurs, the process requires the 
expression of factors that normally regulate mesenchymal myogenesis. 
Second, striated muscle precursors are present during the initial stages of 
esophageal development (Zhao and Dhoot 2000a, b). Third, 
immunocytochemical studies have failed to find unambiguous evidence of the 
simultaneous expression of smooth and skeletal muscle restricted proteins in 
transdifferentiating myocytes (Zhao and Dhoot 2000a, b), which remains the 
major evidence for this hypothesis. Finally, and perhaps most definitive, fate 
mapping studies in which smooth muscle cells were lineage-tagged through 
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expression of the lacZ gene demonstrated unequivocally that esophageal 
skeletal myocytes show no evidence of a prior smooth muscle phenotype 
(Rishniw et al. 2003). One argument advanced in favor of muscle 
transdifferentiation has been the lack of evidence of apoptosis of smooth 
muscle cells during the period of skeletal muscle development (Patapoutian et 
al. 1995) concomitant with the apparent disappearance of the muscularis 
externa (Breuer et al. 2004; Sumiyoshi et al. 2004). However, this hypothesis 
has been recently challenged by exhaustive ultrastructural analysis that 
identified apoptotic cells within developing esophageal muscle (Wörl and 
Neuhuber 2005). Here we address the issue of the fate of smooth muscle cells 
in the embryonic esophagus. We show that the absolute length of the smooth 
muscle component of murine esophagus remains virtually unchanged during 
the first 2 weeks of development; and that smooth muscle cells remain 
scattered throughout the developing and mature striated muscularis externa, 
but adopt atypical smooth muscle morphology. Further, we show that 
myogenin expression occurs in a population of cells distinct from cells 
expressing a smooth muscle specific transgene. We propose that a loss of 
smooth muscle through apoptosis is not an inevitable consequence of 
esophageal striated muscle development and that striated muscle myogenesis 
simply displaces and dilutes at least a portion of the pre-existing smooth 
muscle cells. 
51 Materials and methods 
Tissue preparation 
The smMHCCre-IRES-eGFP (SMCG2) mice and wildtype C57B6J mice 
used in this study were bred at the Core Transgenic Mouse Facility at Cornell 
University College of Veterinary Medicine. The day at which a vaginal plug 
was detected was designated embryonic day 0 (ED0) and parturition date was 
designated as postnatal day 0 (PN0). Mice were killed by CO2 inhalation at 
various embryonic and post-natal stages. Conditional myogenin-null 
(Myog
flox/flox) mice were obtained from the University of Texas. Embryonic and 
neonatal esophagi, along with stomachs and pharynges were dissected out in 
ice-cold phosphate-buffered saline (PBS, pH 7.4), and immediately imaged for 
fluorescence and measured using a dissecting scope (Leica MZ FL3, Leica 
Microsystems Bannockburn, IL) coupled through a digital camera (Optronics 
Magnafire, Optronics Inc., Goleta CA) to image acquisition software 
(Magnafire 2.0, Optronics Inc., Goleta CA). Immediately after imaging, tissues 
were placed on Costar Transwell
® filters (6.5 mm diam, 3 μm pore size, 
Corning Inc., Corning NY) and fixed in 10% formalin for 24 hours at room 
temperature. Fixed esophagi were then embedded in Histogel
® (Richard- Allen 
Scientific, Kalamazoo MI) on a flat surface, and processed for routine 
immunohistochemistry. Adult esophagi were handled in a similar fashion with 
the exception of embedding and fixation: the duodenum was ligated, the 
stomach and esophagus was filled with Histogel, and then ligated at the 
pharynx. Once the Histogel had set, the stomach was trimmed, and the 
esophagus was placed in 10% formalin for 24 hours at room temperature in a 
processing cassette. 
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For c-Kit immunostaining, adult esophagi and stomachs were dissected 
in ice-cold PBS, embedded in OCT medium (Tissue-Tek OCT Compound, 
Sakura Finetek, The Netherlands) and immediately frozen in semi-liquid 
isopentane, chilled in liquid nitrogen.  
Genotyping 
Conditional myogenin null mice (Myog
flox/flox) were mated with SMCG2 
mice to produce SMCG2Myog
flox  /+ offspring. Male SMCG2MyogfloxD/+ 
offspring were backcrossed to Myog
flox/flox females to produce the target 
population SMCG2Myog
flox  /flox   that had myogenin deleted from smooth 
muscle. Myogenin status was identified by PCR genotyping that was 
developed to identify Myog
WT, Myog
flox, and Myog
flox  . Cre recombinase status 
was identified by PCR genotyping for Cre recombinase.  
Immunohistochemistry 
Esophagi were sectioned sagittally either at 4 μm (for standard 
fluorescence microscopy) or 10 μm (for confocal imaging) and mounted on 
poly-lysine coated slides for immunostaining. Immunostaining procedures 
were optimized for each antibody and antibody combination. For c-kit and 
smooth muscle α-actin co-immunostaining, frozen sections were blocked in 
Mouse IgG blocking reagent (M.O.M., Vector labs, Burlingame, CA), TBS 
triton, 10% goat serum, 10% horse serum and 10% non-fat dry milk (NFDM) 
for 20 minutes; incubated at 37ºC for 20 minutes, then at room temperature for 
20 minutes simultaneously with mouse anti-human smooth muscle α-actin 
(1:20, M0851, clone 1A4, Dako-Cytomation Inc., Carpinteria, CA) and rat anti-
mouse c-kit (1:5, RM6200, Caltag Laboratories, Burlingame, CA) antibodies; 
followed by FITC-conjugated horse anti-mouse IgG (1:50, Vector Labs) to 
detect smooth muscle α-actin. Subsequently, biotinylated goat-anti-rat (1:30, 
53 minimum cross-reaction mouse, 112-065-167, Jackson ImmunoResearch, 
Westgrove, PA) and Texas Red Avidin DCS (1:50, A-2016, Vector Labs) were 
applied for 20 minutes at room temperature to detect c-kit positive interstitial 
cells of Cajal (ICC) cells. 
For CD31 (or vWF), and smooth muscle α-actin co-immunostaining, 
fixed sections were microwaved 2 X 10 minutes in citrate (pH 6.0) (CD31) or 
treated with pronase for 20 minutes at 37ºC (vWF); blocked in mouse IgG 
blocking reagent as above, TBS triton, 10% rabbit serum (CD31) or 10% goat 
serum (vWF) and 10% horse serum and 10% NFDM for 20 minutes; incubated 
at 37ºC for 20 minutes, then at room temperature for 20 minutes, 
simultaneously with mouse anti-human Smooth muscle α-actin (1:30, as 
above) and goat anti-rat CD31 (1:50, SC1506, Santa Cruz Biotechnology, 
Santa Cruz, CA) or rabbit anti-human vWF (1:1,500, A0082, Dako-Cytomation 
Inc., Carpinteria, CA) antibodies; detected with FITC-conjugated horse anti-
mouse IgG (as above) to detect smooth muscle α-actin; biotinylated rabbit 
anti-goat IgG (undiluted, 50-232Z Invitrogen Corp., Carlsbad, CA) to detect 
CD31 or biotinylated goat anti-rabbit IgG (1:50, BA-1000,Vector Labs) for 20 
minutes at room temperature, then Texas Red Avidin DCS(1:100, A-2016, 
Vector Labs, Burlingame, CA) to detect vWF.  
For smooth muscle α-actin and Concavalin A immunostaining, fixed 
sections were incubated in pronase for 15 minutes at 37ºC; blocked in mouse 
IgG blocking reagent as above and 10% goat serum for 20 minutes; incubated 
at 37ºC for 2 hours with mouse-antihuman anti-smooth muscle α-actin (1:30, 
M0851, clone 1A4, Dakocytomation Inc., Carpintaria, CA) antibody; detected 
with Texas Red goat anti-mouse IgG (1:100, Molecular Probes, Eugene, OR). 
The sections were then incubated with biotinylated Concavalin A (1:450, 
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B1005, Vector Labs, Burlingame, CA) for 20 minutes at room temperature; 
then streptavidin-conjugated Alexafluor 488 (1:100, Molecular Probes, 
Eugene, OR). 
For Pax-7 and eGFP, Cre recombinase or smooth muscle α-actin co-
immunostaining, fixed sections were steamed in 0.01 M citrate buffer (pH 6.0) 
for 20 minutes. After permeabilization with TBS 0.05% Triton X for 5 minutes, 
a Mouse-on-Mouse (M.O.M.) labeling kit (Vector Labs, Burlingame, CA) was 
used as per instructions for Pax-7 staining (1:2, Developmental Studies 
Hybridoma Bank, Iowa City, IA), substituting Texas Red Avidin (or Streptavidin 
Alkaline phosphatase/DAKO Permanent Red) for the final ABC step. Stained 
sections were held in distilled water overnight, then blocked with 10% goat 
serum. Incubation with rabbit polyclonal GFP antibody (1:4, AB3080, 
Chemicon International Inc., Temecula, CA) or rabbit polyclonal Cre 
recombinase antibody (1:100, PRB-106C, Covance Research Products, 
Berkley, CA) was followed by FITC goat anti-rabbit secondary antibody (1:50, 
FI-1000, Vector Labs, Burlingame, CA). Controls were included, substituting 
normal mouse IgG or rabbit IgG for primary antibodies at appropriate dilutions. 
Additional blocking steps were required for co-immunostaining with two mouse 
primary antibodies (Pax-7 and a-SM actin). Following Pax-7 staining with 
DAKO Permanent Red, samples were blocked in 10% normal horse serum 
and normal mouse IgG blocker (M.O.M., Vector Labs, Burlingame, CA) for 1 
hour, followed by Fab fragment goat anti-mouse IgG (1:50, 115-006-006, 
Jackson Immunoresearch Laboratories, West Grove, PA) for 20 minutes at 
37
oC. Sections were then incubated with mouse-antihuman anti-smooth 
muscle α-actin (1:40, M0851, clone 1A4, Dakocytomation Inc., Carpintaria, 
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Vector Labs, Burlingame, CA). 
Sections used for CD31 and smooth muscle α-actin or eGFP and Pax-7 
staining were additionally mounted in DAPI Vectashield (H-1200, Vector Labs, 
Burlingame, CA) for nuclear visualization. 
For myogenin and Cre recombinase co-immunostaining, fixed sections 
were steamed for 15 minutes in 0.01 M citrate buffer (pH 6.0); blocked in 
mouse IgG blocking reagent as above, TBS triton, 10% goat serum and 10% 
NFDM for 20 minutes; incubated at 37ºC for 2 hours with mouse anti-rat 
myogenin (1:30, M3559, DakoCytomation Inc., Carpinteria, CA), then with 
biotinylated anti-mouse (M.O.M., Vector Labs, Burlingame, CA) for 20 minutes 
at room temperature; followed by streptavidin-conjugated Alkaline 
phosphatase (1:200, Vector Labs, Burlingame, CA), and finally, myogenin was 
detected with Permanent Red (K0640, DakoCytomation Inc., Carpinteria, CA). 
The slides were then incubated with rabbit anti-Cre recombinase (1:100, PRB-
106C, Covance Research Products, Berkley, CA) for 2 hours at 37ºC and 
detected with FITC-labeled goat anti-rabbit IgG (1:50, 65-6111, Zymed 
Laboratories, Carlsbad, CA). Apoptosis was detected by staining fixed 
sections stained with Hoechst 33342 (1:1,000, H3570, Invitrogen Corp., 
Carlsbad, CA); sections were incubated at room temperature for 5 minutes, 
washed and mounted in Vectashield (Vector Labs, H-1000, Burlingame, CA). 
The Pax-7 monoclonal antibody developed by Atsushi Kawakami was 
obtained from the Developmental Studies Hybridoma Bank developed under 
the auspices of the NICHD and maintained by the University of Iowa, 
Department of Biological Sciences, Iowa City, IA 52242. 
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Imaging 
Fluorescent microscopy was performed using a Fluorescent 
microscope (AX70 or BX51, Olympus America, Melville, NY). Confocal 
microscopy was performed with a inverted microscope (Nikon TE300, Nikon 
USA or Olympus IX81) with a confocal scanhead attachment (Radiance 2000, 
Bio-Rad Laboratories, Hercules, CA or FV1000, Olympus America, Melville, 
NY). All fluorescent images were acquired with filters optimized for the 
emission spectra of the fluorophores used. Three-dimensional models of SM 
cells and adjacent tissues were created using Volocity 3.0 (Improvision Inc., 
Lexington, MA).  
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To estimate cross-sectional area of the muscularis externa at E14.5 
and adult, digital images of sagittal sections were acquired. The inner and 
outer diameters of the muscularis externa were obtained and the cross-
sectional area was calculated as 
where do is the outer diameter of muscularis externa and di is the inner 
diameter of muscularis externa. Length measurements of the esophagi were 
obtained from digital image files using ImageJ software (ImageJ 1.33U, NIH, 
Bethesda, MD) with measuring tools developed in our laboratory. Length of 
the fluorescent portion of whole-mount esophagi was determined using 
ImageJ using the measuring tool and examining the profile plot of the pixel 
intensity along the measurement line. The point at which pixel intensity (grey 
57 value) decreased by 50% of the pre-gastric esophageal pixel intensity was 
assigned as the limit of fluorescent portion of the esophagus. Esophagi were 
laid out on Petri dishes for imaging, which slightly stretched them compared to 
their in vivo lengths. 
 
Results 
Absolute length of the smooth muscle portion of the muscularis 
externa remains unchanged during a 2-fold increase in esophageal 
length.  To investigate the fate of esophageal smooth muscle cells, we 
isolated esophagi from ED14.5, PN2-3, PN8-10, and PN21 SMCG2 transgenic 
mice, in which the expression of Cre recombinase and eGFP is restricted to 
smooth muscle by the smooth muscle myosin heavy chain promoter (Xin et al. 
2002; Rishniw et al. 2003), and measured the length of the fluorescent portion 
of the esophagus and total esophageal length (Figure 3.1A–D). Whole-mount 
esophagi from ED14.5 mice measured 4.7 mm (n = 6) and smooth muscle 
fluorescence extended along the entire length of the esophagus, consistent 
with our previously published results (Rishniw et al. 2003) (Figure 3.1A and 
Figure 3.2). Whole-mount esophagi from PN2-3 mice measured 9.6 mm (n = 
13) and fluorescence was largely restricted to the caudal 50% of the 
esophagus and the length of the fluorescent smooth muscle portion measured 
4.8 mm (Figure 3.1B and Figure 3.2). In PN8-10 mice, the esophagus 
measured 15 mm (n = 4), and smooth muscle fluorescence was observed 
along the distal 4 mm of the esophagus (Figure 3.1C and Figure 3.2). In PN21 
mice, at which time esophageal development has been completed, gross 
fluorescence was limited to a small region (approximately 1.5 mm) at the lower 
esophageal sphincter (Figure 3.1D). 
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We next obtained full-length sagittal histological sections of esophagi 
from SMCG2 mice, labeled them with anti-smooth muscle α-actin or anti-GFP 
antibodies, and measured the length of the smooth muscle portion of the 
muscularis externa. The results were similar to those obtained with gross 
fluorescent measurements (Figure 3.1E–H). Esophagi from ED14.5 mice 
measured 4.2 mm with a smooth muscle portion of 4.2 mm; those from PN3 
mice measured 7.8 mm, with a smooth muscle portion of 4.3 mm; those from 
PN8 mice measured 11 mm with a smooth muscle portion of 3 mm and those 
from PN21 or adult mice measured 25–35 mm with a smooth muscle portion 
of approximately 1–1.5 mm (Figure 3.2). 
Thus while the esophagus undergoes a substantial change in length 
(from 3 mm to 10–15 mm) (Figure 3.2), the linear dimension of the smooth 
muscle portion remains relatively unchanged, even though the proportion of its 
contribution to the total esophageal muscularis externa decreases by 
approximately 75%.  
These findings suggest that marked smooth muscle apoptosis is 
unlikely to occur over this period, particularly in light of the likelihood of tissue 
compaction during this period. To further investigate the possibility of 
apoptosis, which has recently been proposed as a mechanism by which 
esophageal developing smooth muscle disappears (Wörl and Neuhuber 
2005), we stained full-length 4 μm thick sagittal esophageal sections of PN8 
mice, where approximately 70% of the esophagus is striated, with Hoechst 
33342, which identifies apoptotic nuclei. We could only identify occasional 
apoptotic cells in these sections. 
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Figure 3.1  Smooth muscle expression is progressively restricted during 
development to the caudal esophagus.  Extent of the smooth muscle 
component of esophagi from ED14.5 (A, E), PN2-3 (B, F), PN8-10 (C, G) and 
PN21 (D, H) smMHC-Cre-IRES-eGFP (SMCG2) transgenic mice.  
Fluorescence of fresh whole-mount esophagi from SMCG2 mice (A-D), wide-
field fluorescent smooth muscle α-actin labeling (E-H), shows a progressive 
restriction of smooth muscle to the caudal esophagus during esophageal 
maturation.  Dashed line in panels B-D represents the approximate portion of 
the esophagus measured as fluorescent.  LES = Lower Esophageal Sphincter.  
Scale bar = 1mm. 
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The general conservation and progressive confinement of smooth 
muscle tissue to the caudal esophagus, suggest that marked smooth muscle 
apoptosis is unlikely to occur over this period. However, a progressive 
decrease in the length of the smooth muscle segment of the muscularis 
externa by adulthood suggests that simple compaction of the initial muscle 
might not fully explain smooth muscle cell fate, and gradual apoptotic loss may 
account for some of the decrease in smooth muscle tissue. 
 
Figure 3.2  Extent of smooth muscle expression is constant during early 
esophageal growth.  The absolute length of the smooth muscle portion 
between ED14.5 and PN8-10 does not change substantially despite a 3-fold 
increase in total esophageal length. 
 
Remnant smooth muscle cells persist throughout the developing 
and mature striated muscle component of the muscularis externa.  
Examination of esophagi from PN8 SMCG2 mice revealed discrete, linear 
areas of fluorescence within the skeletal muscularis externa in the 
subpharyngeal esophagus, similar to that exhibited by smooth muscle cells in 
a more dense pattern near the lower esophageal sphincter. These smooth 
muscle cells were also observed with confocal imaging of freshly isolated 
whole esophagus (Figure 3.3A). Sparse fluorescent cells were also observed 
subpharyngeally in the developing stages PN2-3 (not shown). The oblique 
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cells in the pregastric esophagus and the orientation of striated muscle fibers 
throughout the esophagus. We could not identify fluorescent cells in adult 
esophagi using widefield fluorescent microscopy, because of background 
fluorescence. However, similar fluorescent cells were observed with confocal 
imaging in freshly isolated whole adult esophagi (Figure 3.3B). These findings 
suggested a persistence of smooth muscle cells near the serosal surface of 
the muscularis externa. We consequently performed a series of 
immunohistochemical studies to determine the nature of these apparent 
smooth muscle cells. 
 
Figure 3.3  Remnant smooth muscle cells in the sub-pharyngeal portion 
of the mouse esophagus.  Confocal z-projections through fresh whole-mount 
esophagi from PN8-10 (A) and adult (B) smCG2 mice showing linear 
endogenously expressed GFP fluorescence in the subserosal muscularis 
externa. Scale bar = 50μm. 
 
Remnant smooth muscle cells express smooth-muscle actin and 
demonstrate an atypical morphology.  Sagittal sections of developing and 
adult esophagus and stomach were labeled with anti-smooth muscle actin, 
which is restricted to smooth muscle in adult mice and is transiently expressed 
in atrial muscle, as well as expressed in committed smooth muscle, during 
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development (Babai et al. 1990; Nehls and Drenckhahn 1991; 
Borirakchanyavat et al. 1997). To verify this, we examined gastric smooth 
muscle cells from SMCG2 mice for co-expression of eGFP and smooth 
muscle α-actin. Typical smooth muscle cells showed eGFP fluorescence 
throughout the cytoplasm, with periplasmic labeling of smooth muscle α-actin 
(data not shown). We then examined the striated muscle portion of the 
esophageal muscularis externa for smooth muscle α-actin labeled cells. 
Occasional small and elongated smooth muscle cells were observed tightly 
associated with striated muscle fibers, and these cells increased in frequency 
along the muscularis externa nearer the lower esophageal sphincter (Figure 
3.4A, B, D). At the transition zone, where striated muscle is replaced by 
smooth muscle over a small region, there were mixtures of smooth muscle 
cells that were similar in appearance to the remnant smooth muscle cells 
found more cranially, as well as more typical smooth muscle cells. In contrast 
to pre-gastric smooth muscle cells, the remnant smooth muscle cells 
contained very little cytoplasm. Confocal images and 3D reconstructions 
suggested that these remnant smooth muscle cells were nucleated and 
flattened (Figure 3.4E). Additionally, examination of appendicular striated 
muscle (semimembranosus and semitendinosus) revealed only vascular SM 
cells, further supporting our hypothesis that remnant smooth muscle cells 
occur only in esophageal striated muscle. 
Remnant smooth muscle cells are different from vascular smooth 
muscle cells or pericytes.  To determine if the remnant smooth muscle cells 
were vascular smooth muscle cells, we labeled sagittal esophageal sections 
with anti-smooth muscle α-actin antibodies and endothelial markers (anti-
vonWillebrand Factor-related Antigen or anti-CD31 antibodies). 
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Figure 3.4  Remnant smooth muscle cells are intimately associated with 
striated muscle in esophageal muscularis externa, and are not vascular 
SM cells.  Confocal z-projections of muscularis externa (A-C) from adult 
SMCG2 mice showing SM cells (red) and vascular endothelium (green).  
Vascular smooth muscle cells co-localize with vascular endothelium as an 
irregular circumferential network (C), however remnant smooth muscle cells 
are single, nucleated cells that are separate from any vascular labeling.  Some 
remnant smooth muscle cells have faint green cytoplasmic GFP fluorescence 
(arrows, C).  They are intimately associated with striated muscle (A, B, D), and 
have a flattened and irregular phenotype, as evidenced by 3D reconstruction 
(E).  Magnification for A-D is 40x. 
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muscle cells was observed along small blood vessels in close association with 
endothelial markers (Figure 3.4C), we observed remnant smooth muscle cells 
separate from any vascular staining (Figure 3.4A, B).  Further, vascular 
smooth muscle cells were oriented circumferentially around blood vessels 
(Ushiwata and Ushiki 1990; Bizuneh et al. 1991; Pannarale et al. 1996; 
Higuchi et al. 2000) and appeared almost as a thin syncytium or mesh of 
smooth muscle α-actin-staining cells, whereas the remnant smooth muscle 
cells often lay parallel to the microvasculature, and were discrete, well-defined 
cells. 
Similarly, the morphology of remnant smooth muscle cells differed from 
the reported morphology and localization of vascular pericytes (Nehls and 
Drenckhahn 1991; Pannarale et al. 1996; Hughes and Chan-Ling 2004). 
Finally, as stated previously, no such cells were observed in appendicular 
striated muscles, where only vascular smooth muscle cells were observed. 
Thus, remnant smooth muscle cells appear to be distinct from vascular 
smooth muscle cells or pericytes. 
 
Remnant smooth muscle cells are not satellite cells and are 
separate from striated muscle cells.  To determine if the remnant smooth 
muscle cells were satellite cells, we examined the muscularis externa of 
smCG2 transgenic mice for co-expression of eGFP or Cre recombinase, which 
are selectively expressed in smooth muscle cells of SMCG2 mice, or smooth 
muscle α-actin in wildtype and SMCG2 mice, and Pax7, which is expressed in 
adult striated muscle satellite cells (Seale et al. 2000). We used striated 
appendicular muscle as a control. Satellite cells were identified throughout the 
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B), but these cells did not co-express eGFP, Cre recombinase or smooth 
muscle α-actin.  
 
Figure 3.5  Remnant smooth muscle cells are not satellite cells.  
Fluorescent wide-field images showing Pax7-labeled cell nuclei (pink) and 
eGFP-labeled (A) or Smooth muscle α-actin (B) SM cells (green) in adult 
SMCG2 mice.  Pink satellite cell nuclei can be seen in esophageal muscularis 
externa, separate from remnant smooth muscle cells, which have blue-staining 
nuclei (A). 
In contrast to satellite cells, cytoplasmic projections from the remnant 
smooth muscle cells spanned striated muscle fibers, and diverged from the 
striated muscle fibers, indicating that they were not encapsulated by the same 
basement membrane as the fiber (Figure 3.6A, B). These findings indicate that 
remnant smooth muscle cells are not satellite cells. 
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Figure 3.6  Remnant smooth muscle cells span multiple striated 
muscles.  Confocal Z-scan images showing remnant smooth muscle cells 
(red) spanning multiple Concavalin A-labeled striated muscle fibers (green)(A), 
and diverging from adjacent striated muscle fibers (B, arrow).  Magnification 
60x. 
 
Remnant smooth muscle cells are different from ICC.  There is 
speculation that some smooth muscle develops from a c-kit expressing 
precursor cell, which matures into either ICC or smooth muscle (Ward and 
Sanders 2001). Additionally, ICC are scattered throughout the adult murine 
esophagus (Vanderwinden et al. 2000; Rumessen et al. 2001) but the 
expression of smooth muscle α-actin by ICC has not been investigated. 
Therefore, to determine if remnant smooth muscle cells are ICC, we labeled 
sagittal sections of developing and adult stomach (Figure 3.7A) and 
esophagus (Figure 3.7B, C) with anti-smooth muscle α-actin and anti-c-kit 
antibodies. Remnant smooth muscle cells were often (but not always) 
intimately associated with ICC within the striated muscle portion of the 
muscularis externa (Figure 3.7B, C) but we did not observe any co-staining, 
indicating that remnant smooth muscle cells are not ICC. Gastric ICC failed to 
label with anti-smooth muscle α-actin antibodies, indicating that ICC do not 
express smooth muscle actin (Figure 3.7A). 
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Figure 3.7  Remnant smooth muscle cells are not interstitial cells of 
Cajal.  Confocal Z-projection of gastric muscularis externa (A) shows separate 
labeling of ICC (red) and smooth muscle cells (green) in adult SMCG2 mice.  
Fluorescent wide-field image of adult murine esophagus shows remnant 
smooth muscle cells intimately associated with c-kit positive ICC (B, upper 
left), as well as isolated ICC (B, red, lower right) and isolated remnant smooth 
muscle cells (B, green, middle right).  Confocal Z-projection shows intimate 
association of ICC and remnant smooth muscle cells in esophageal 
muscularis externa (C).  Magnification 40x (B), 120x (A, C). 
Remnant and typical esophageal smooth muscle cells do not 
transdifferentiate into striated muscle cells.  As the principal evidence for 
smooth muscle transdifferentiation is the coexpression of smooth muscle 
specific proteins and skeletal myogenic factors, (Patapoutian et al. 1995) we 
examined the co-expression of a marker of striated myogenesis (myogenin) 
and a transgene driven by the smooth muscle-specific myosin heavy chain 
promoter in PN2-3 and PN8-10 SMCG2 transgenic mice. Sagittal esophageal 
sections were labeled with antibodies directed at myogenin and Cre 
recombinase, which contains a nuclear localization signal. The myogenin 
antibody labeled nuclei along the length of the developing esophagus, with a 
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concentration of stained nuclei at the ‘‘transition zone’’ between smooth and 
striated muscle, but also more dilute staining of nuclei along the caudal 
esophagus, ‘‘ahead’’ of the myogenic wave-front. The Cre recombinase 
antibody labeled nuclei of all smooth muscle cells within the stomach, and 
both esophageal layers (muscularis mucosae and muscularis externa). 
Nuclear colocalization of the two antibodies was never observed in embryonic 
esophagi, at a time when esophageal smooth muscle is being progressively 
replaced by skeletal myocytes (Figure 3.8A, B).  
 
 
Figure 3.8  No evidence of transdifferentiation in murine muscularis 
externa.  Confocal z-projections from cranial (A) and caudal (B) regions of 
esophageal muscularis externa from a PN8-10 SMCG2 mouse show no 
colocalization of nuclear Cre-recombinase labeling (green) and nuclear 
myogenin labeling (red).  Inset panels show higher detail of myogenin staining 
at both ends of the esophagus.  Magnification 60X (A,B). 
These results further suggest that smooth muscle cells do not 
transdifferentiate into striated muscle. 
Myogenin is a myogenic transcription factor that is essential for striated 
myogenesis but not smooth muscle or cardiac muscle development and 
inactivation of the myogenin gene results in striated muscle deficiency and 
neonatal death (Hasty et al. 1993). 
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Figure 3.9  Fetal smooth-muscle-specific myogenin inactivation fails to 
affect striated esophageal myogenesis.  (A) PTAH-stained longitudinal 
section of the lower esophageal sphincter of a PN21 SMCG2Myog
flox∆/flox∆ 
shows normal extension of striated muscle to the perigastric border.  (B) 
Immunohistochemical staining for Cre-recombinase shows robust expression 
in gastric smooth muscle.  Magnification 4X (A), 20X (B), scale bar = 1mm. 
 
We reasoned that if transdifferentiation of esophageal muscularis externa 
occurred, deletion of myogenin from smooth muscle cells during development 
would disrupt striated esophageal myogenesis, resulting in either a complete 
or partial failure of striated esophageal myogenesis. We tested this hypothesis 
by deleting myogenin from smooth muscle in conditional Myogenin knockout 
(Myog
flox/flox) mice by mating them with SMCG2 mice (Knapp et al. 2006).  
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Esophageal myogenesis was unaffected by smooth muscle specific gene 
inactivation (Figure 3.9),which occurs prior to significant esophageal striated 
myogenesis (Madsen et al. 1998; Rishniw et al. 2003), further substantiating 
our hypothesis that striated esophageal muscle do not transdifferentiate from 
smooth muscle cells. 
 
Discussion 
We have identified a persistent population of non-vascular smooth 
muscle cells in developing and adult murine esophagus within the striated 
muscle portion of the muscularis externa and have shown that, while the 
proportion of smooth muscle contributing to the total muscularis externa 
decreases with development, its absolute length changes very little for much 
of the developmental period. These findings offer evidence of the fate of a 
portion of esophageal smooth muscle cells which complement the recent 
observations of apoptosis, and provide a valid alternative hypothesis to 
transdifferentiation. Moreover, we have shown that protein expressed by 
committed smooth muscle cells (expressing Cre recombinase under control of 
the smMHC promoter) is not co-expressed with the striated muscle myogenic 
regulatory factor (MRF), myogenin, as would be expected with an overlap of 
smooth and skeletal muscle phenotypes, as previously suggested 
(Patapoutian et al. 1995). Taken together, these results lend further support to 
the hypothesis that skeletal myogenesis occurs independent of pre-committed 
smooth muscle cells and that embryonic smooth muscle persists in both a 
compacted form (near the lower esophageal sphincter) and as a group of cells 
that have been diluted by skeletal myogenesis and persist throughout the 
length of the adult esophagus. 
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esophageal smooth muscle cells appear to be distinct from vascular smooth 
muscle, pericytes, ICC, or satellite cells. Their morphology is markedly 
distorted from normal smooth muscle cells, such as those found near the 
lower esophageal sphincter or within the gastric muscularis externa, but is 
similar to some of the smooth muscle cells found in the ‘‘transition zone’’ 
where striated muscle begins to encroach on the smooth muscle layer. 
Remnant smooth muscle cells appear to be constricted by surrounding striated 
muscle fibers, often with thin sheet-like cytoplasmic projections that follow the 
contours of the striated muscle sarcolemma. In several instances, remnant 
smooth muscle cells appear to be closely associated with ICC that have been 
previously identified within the striated muscle portion of the esophageal 
muscularis externa (Ward et al. 1996; Vanderwinden et al. 2000; Rumessen et 
al. 2001). It is tempting to speculate that the remnant smooth muscle cells 
provide a supportive function for these ICC, since ICC exist in an exclusively 
smooth muscle environment in the rest of the body. How the remnant smooth 
muscle cells come to be surrounded by striated muscle remains unknown, 
however these findings argue against a discrete myogenic zone in which 
striated muscle cells develop. While myogenin staining of developing 
esophagus shows a region of higher myogenin expression that progresses 
caudally at incremental developmental stages, myogenin expression appears 
to be more diffuse than previously reported, with discrete striated muscle 
precursors being visible caudal to the ‘‘myogenic zone’’ (Figure 3.10). This is 
consistent with observations by Wörl and Neuhuber, who identified striated 
muscle precursor cells throughout the smooth muscle portion of developing 
esophagi (Wörl and Neuhuber 2005). Sagittal sectioning of fetal and neonatal 
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esophagus allowed unambiguous identification of such occasional myogenin-
positive cells, whereas previous studies relied on transverse whole-embryo 
sections.  While this observation does not rule out transdifferentiation, it does 
argue against a discrete ‘‘myogenic zone’’. We suggest that as striated muscle 
precursors activate their myogenic program and proliferate as myoblasts to 
finally form myotubes, they surround occasional SM cells, and sequester them 
from their smooth muscle cell neighbors. 
 
Figure 3.10  Myogenin expression proceeds craniocaudally in a diffuse 
manner, rather than as a discrete zone.  Fluorescent wide-field image of a 
sagittal section of esophagus from a PN2 mouse showing a diffuse pattern of 
myogenin expression (red punctuate fluorescence), rather than a discrete 
zone of active myogenesis with myogenin expression extending to within 1mm 
of the lower esophageal sphincter. Scale bar = 500 μm  
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separates these remnant smooth muscle cells, much as two dots on the 
surface of an inflating balloon move further and further apart. This process 
appears to be occurring at the very earliest stages of esophageal myogenesis, 
because remnant smooth muscle cells can be found immediately below the 
pharynx. While the remnant smooth muscle cells are sparsely scattered 
throughout the muscularis externa, and it is not possible to estimate their 
number in adult mice in this study, they could account for a substantial portion 
of the smooth muscle cells present at ED14.5. 
Sagittal sections of ED14.5 esophagus show that the two layers of the 
muscularis externa are cumulatively 2–4 cells thick (Figure 2.3), so the total 
number of smooth muscle cells at this stage is relatively small. With a >10-fold 
increase in esophageal length between ED14.5 and adults (3–30 mm), and a 
>10-fold increase in cross-sectional area (0.03 to >0.3 mm
2), the volume of the 
muscularis externa increases 100-fold. If the smooth muscle mass present at 
ED14.5 is preserved, or even decreases slightly (as is suggested by the 
shapes of the remnant smooth muscle cells), it would only account for 1% of 
the total volume of the muscularis externa in adulthood. Thus, it is feasible that 
many of the smooth muscle cells, present as a continuous organ at day 
ED14.5, become dispersed remnant smooth muscle cells in adulthood. 
Previous investigators have hypothesized that skeletal myogenesis ‘‘dilutes’’ 
the pre-existing smooth muscle cells, (Zhao and Dhoot 2000a), although the 
persistence of these cells has not been previously demonstrated. 
Preservation of smooth muscle portion of mouse esophagus.  We 
previously demonstrated, through fate mapping experiments using a Cre-LoxP 
system and an irreversibly activated Cre recombinase-dependent reporter  
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(β-galactosidase), that committed smooth muscle cells expressing smooth 
muscle myosin heavy chain, did not transdifferentiate into striated muscle cells 
in esophageal muscularis externa (Rishniw et al. 2003). However, several 
investigators have questioned these results on the basis of a lack of 
demonstration of an alternative fate of smooth muscle cells other than as 
conversion to skeletal myocytes (Breuer et al. 2004; Sumiyoshi et al. 2004), 
since Patapoutian et al. had previously shown no evidence of smooth muscle 
apoptosis (Patapoutian et al. 1995). The current results provide an alternative 
model regarding the developmental fate of esophageal smooth muscle cell. If 
smooth muscle cells accounted for the development of skeletal myocytes that 
ultimately fuse to form the muscularis externa, one would expect to see a 
distinct reduction in the size of the smooth muscle portion early in 
development, as the smooth muscle cell pool is depleted at the expense of a 
growing striated muscle pool. Even in the first 7 days of development when the 
mouse esophagus more than doubles in length, however, the smooth muscle 
portion of the esophagus remains virtually unchanged. This is supported by 
findings of Reddy and Kablar (2004), who demonstrated that in mice lacking 
essential MRFs (Myf5 and MyoD), esophageal smooth muscle remained 
static, but did not ‘‘disappear’’. While these authors interpreted their results as 
indicating a failure of transdifferentiation, an identical outcome would be 
expected if skeletal myogenesis occurred independently via mesenchymal 
precursors. Although our results do not discount the recent observations of 
apoptosis (Wörl and Neuhuber 2005), we did not observe the same extent of 
apoptosis in developing esophagi. Indeed, the results of Reddy and Kablar 
suggest that apoptosis is not a major fate of esophageal smooth muscle cells, 
although factors that might trigger apoptosis could be absent in mice lacking 
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the persistence of smooth muscle in the adult esophagus. Zhao and Dhoot 
temporally mapped four MRFs in developing mouse esophagus from ED13 to 
PN1, demonstrating the pattern and extent of MRF activation along the entire 
esophageal length (Zhao and Dhoot 2000b). Interestingly, the nonactivated 
region of tissue, which remained caudal as the esophagus grew, did not shrink 
substantially over this period—it measured 2–3 mm at ED13 and 2–3 mm at 
PN1. This region corresponds to the smooth muscle portion of the developing 
esophagus. Our findings support these data, suggesting that smooth muscle 
disappearance is not a pre-requisite for esophageal development. We suspect 
that the smooth muscle cells simply become dispersed throughout the striated 
muscle, or re-organized in the pre-gastric region to accommodate the 
substantial increase in esophageal size. 
 
No transdifferentiation in mouse esophagus.  Finally, we failed to 
observe any nuclear colocalization of smooth muscle protein and striated 
muscle MRF in developing esophagi and failed to arrest or disrupt striated 
myogenesis with targeted deletion of myogenin from embryonic esophageal 
smooth muscle. This contradicts the findings of Patapoutian et al. who 
observed MRF (MyoD) expression in cells that expressed smooth muscle cell 
markers (Myosin Light Chain Kinase, MLCK) (Patapoutian et al. 1995). 
However, other investigators have subsequently noted that MLCK is not an 
appropriate marker of smooth muscle cells in developing muscle, because it is 
transiently expressed in striated muscle (DallaLibera et al. 1997; Zhao and 
Dhoot 2000a). Conversely, smooth muscle myosin heavy chain is exclusively 
restricted to smooth muscle cells (with the exception of transient expression in 
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the developing atrium, Regan et al. 2000; Xin et al. 2002), and therefore 
serves as a specific marker of smooth muscle cells. We had previously 
created a Cre recombinase expressing transgenic mouse where Cre 
recombinase was under the control of the smooth muscle myosin heavy chain 
promoter (smCG2) (Xin et al. 2002) and used this mouse in our fate mapping 
experiments (detailed above) (Rishniw et al. 2003). Therefore, Cre 
recombinase expression would be anticipated in any smooth muscle cell, or 
cell that had recently transdifferentiated from a smooth muscle cell and was 
expressing myogenin. It is possible that expression of these two proteins 
would not overlap temporally, (the half-life of expressed Cre recombinase is 
unknown). However, in a region of high myogenin expression, we would 
expect some co-expression of Cre recombinase (persisting from prior smooth 
muscle cell phenotype) and myogenin (newly expressed in a 
transdifferentiating cell). We failed to observe any such colocalization, which 
strongly argues against transdifferentiation of smooth muscle cells in mouse 
esophagus and supports our previous study. While the immunohistochemical 
data may fail to detect temporally dissociated events, such as expression of 
Cre recombinase and myogenin, targeted deletion of myogenin in smooth 
muscle would prevent smooth muscle cells from transdifferentiating into 
striated muscle. Had myogenin been inactivated in smooth muscle that 
subsequently transdifferentiated into striated muscle, we would expect to 
observe arrested, failed or abnormal striated esophageal myogenesis. We 
have previously demonstrated robust Cre recombinase expression in 
developing mouse esophageal smooth muscle at a time when striated muscle 
is virtually undetectable, indicating that any conditionally deletable allele will be 
inactivated (Rishniw et al. 2003; Madsen et al. 1998). However, we failed to 
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in smooth muscle. Together, these data offer strong evidence that esophageal 
striated muscle does not arise by transdifferentiation from smooth muscle. 
While some studies have demonstrated the plasticity of vascular smooth 
muscle cells (Wang et al. 2006), these studies have not definitively 
demonstrated transdifferentiation rather than differentiation from a common 
mesenchymal stem cell pool. Moreover, no studies of which we are aware 
have unequivocally demonstrated transdifferentiation into striated muscle, 
although one study has suggested the ability of striated myocytes to 
transdifferentiate into smooth muscle cells in a jellyfish species (Galle et al. 
2005). 
 
An alternate model of esophageal myogenesis.  Taken together, our 
data, and those of previous investigators, suggest that striated myogenesis 
arises from a distinct population of myogenic precursors, rather than via 
transdifferentiation from smooth muscle cells, and their apparent 
‘‘disappearance’’ can be explained morphometrically. We suggest that the fetal 
esophageal smooth muscle cells adopt one of three fates during the 
expansion of the striated muscle mass: (1) a small subset of smooth muscle 
cells are ‘‘trapped’’ within the expanding striated muscle tissue, giving rise to 
the remnant smooth muscle cells we have described in this study; (2) a subset 
undergoes apoptosis, as identified by other investigators (Wörl and Neuhuber 
2005); and (3) the large majority of smooth muscle cells are compacted 
distally to give rise to the lower esophageal sphincter and the junctional region 
that can be clearly identified in adult mice, as is suggested by this study. In 
conclusion, our data provide evidence for persistence of smooth muscle cells 
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within the developing and adult esophagus and are supported by findings of 
previous studies. Taken together, these findings provide an alternative model 
for esophageal development that does not require transdifferentiation to 
account for the apparent ‘‘disappearance’’ of smooth muscle cells. 
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Striated myogenesis and peristalsis in the fetal murine esophagus 
occurs without cell migration or interstitial cells of Cajal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Originally published as: Rishniw M et al. Striated myogenesis and peristalsis in the fetal 
murine esophagus occurs without cell migration or interstitial cells of Cajal.  Cells Tissues 
Organs 2008 (epub ahead of print).  Reproduced with permission.  
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Abstract 
Esophageal striated myogenesis progresses differently from 
appendicular myogenesis, but the mechanism underlying this process is 
incompletely understood.  Early theories of transdifferentiation of smooth 
muscle into striated muscle are not supported by transgenic fate-mapping 
experiments, however, the origin of esophageal striated muscle remains 
unknown.  To better define the process of striated myogenesis, we examined 
myogenesis in murine fetal cultured esophageal whole-organ explants.  
ED14.5 esophagi maintained a functional contractile phenotype for up to 7 
days in culture.  Striated myogenesis, as evidenced by myogenin expression, 
proceeded in a cranio-caudal direction along the length of the esophagus.  
Esophageal length did not change during this process.  Complete, but not 
partial, mechanical disruption of the rostral esophagus inhibited myogenesis 
distally.  Addition of FGF-2 to the culture media failed to inhibit striated 
myogenesis, but attenuated smooth-muscle actin expression and reduced 
peristaltic activity.  Inhibition of c-kit failed to inhibit peristalsis.  These results 
suggest that striated myogenic precursors are resident along the entire length 
of the esophagus by ED14.5 and do not migrate along the esophagus after 
ED14.5. Induction of myogenesis cranio-caudally appears to require physical 
continuity of the esophagus and is not inhibited by FGF-2.  Finally, peristalsis 
in ED14.5 esophagi appears not to be regulated by Interstitial Cells of Cajal. 
85 Introduction 
Esophageal striated myogenesis is a complex process that differs from 
striated myogenesis elsewhere in the body.  The muscularis externa of the 
murine esophagus initially develops as a smooth muscle tube, apparent by 
day ED9-10, but then transforms into an almost exclusively striated muscle 
tube over the following 3 weeks (Zhao and Dhoot 2000a; Zhao and Dhoot 
2000b; Zhao and Dhoot 2000c; Rishniw et al., 2003; Wörl and Neuhuber 
2005; Rishniw et al., 2007). 
Approximately 50% of this smooth-to-striated muscle transformation 
occurs post-natally (Rishniw et al., 2007).  Although initially hypothesized to 
occur via transdifferentiation of smooth muscle cells into striated muscle cells 
(Patapoutian et al., 1995; Kablar et al., 2000; Stratton et al., 2000), more 
recent studies have provided compelling evidence that striated muscle cells 
arise from a distinct and separate population of precursors (Zhao and Dhoot 
2000a; Zhao and Dhoot 2000b; Zhao and Dhoot 2000c; Rishniw et al., 2003; 
Wörl and Neuhuber 2005; Rishniw et al., 2007).  Studies have shown three 
independent fates of esophageal smooth muscle cells: apoptosis (Wörl and 
Neuhuber 2005), persistence within the striated muscle layer as remnant 
smooth muscle cells (Rishniw et al., 2007), and compaction into the lower 
esophageal sphincter (Rishniw et al., 2007). 
The origin of striated muscle cells and the means by which they 
populate the esophagus remain largely undetermined.  Skeletal myoblasts 
could differentiate from pluripotent mesenchymal stem cells within the 
esophagus, although this seems unlikely given that other striated muscle 
precursors arise from neural crest cells that have migrated either to form 
somites or to other regions (e.g. facial muscles).  Alternatively, neural crest 
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cells similar to those that give rise to pharyngeal and lingual muscles could 
migrate to the esophagus during early esophageal development, forming a 
resident population of myogenic precursors.  Lingual and pharyngeal striated 
muscles are apparent by ED10.5, while esophageal striated muscle cells are 
not detected before ED11.5-12.5, indicating that if simultaneous migration 
occurs, myodifferentiation must be slightly delayed relative to other non-
somatic muscle.  Finally, it is possible that a later migration of precursors 
derived from somites or neural crest could occur, giving rise to striated 
myogenesis in a rostral to caudal pattern. 
To address the myogenic potential of the embryonic mouse esophagus 
and further define this process, we examined striated myogenesis ex vivo.  
Using wild-type and SMCG2 transgenic fetuses, we cultured esophageal 
explants in toto for up to 7 days, and examined myogenesis and esophageal 
functional integrity by immunohistochemical, fluorescent microscopic and 
pharmacological means, using fibroblast growth factor (FGF-2) and 
neutralizing anti-ckit antibodies to alter either myogenesis or peristalsis.  Our 
study demonstrates that striated myogenesis occurs in the explanted ED14.5 
esophagus maintained in organ culture in a rostro-caudal direction and is 
dependent on the physical integrity of the esophagus and unaffected by 
exposure to FGF-2.  Finally, we show that cultured fetal esophagi display 
prominent peristaltic contractions for up to 7 days in culture and this peristalsis 
is not dependent on interstitial cells of Cajal. 
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Organ culture 
Female C57BL/6J mice were mated with male SMCG2
+/WT transgenic 
mice (these mice are maintained as hemizygous transgenic mice and express 
Cre recombinase and eGFP under the control of a smooth-muscle myosin 
heavy chain promoter – thus the aforementioned mating would produce, on 
average, 50% wildtype fetuses, and 50% hemizygous transgenic fetuses) and 
euthanatized by CO2 asphyxiation 14.5 days post coitus as approved by the 
Institutional Animal Care and Use Committee.  Uteri were immediately excised 
and placed in sterile Petri dishes on ice, and fetuses removed and placed in 
ice-cold PBS (pH7.4) on ice.  Fetal esophagi were explanted in toto, with 
tongue, pharynx/larynx and stomach attached in ice-cold PBS using a 
dissecting microscope (magnification 18X-30X), transferred immediately onto 
6.5 mm diameter 3 µm pore size polycarbonate membrane filters (Transwells, 
Corning, Inc., Corning, New York), and incubated in 270 µL organ culture 
media (BGJb media, 10mg/ml Ascorbic acid, 20% heat-inactivated fetal calf 
serum, penicillin/streptomycin/amphotericin) at 37ºC in 5%CO2 for up to 7 
days.  Media were exchanged every 12 hours.  Motility was assessed every 24 
hours by observing each of the esophagi in culture on an inverted dissecting 
scope for up to 2 minutes each and timing contraction intervals.  For esophagi 
that were transected or partially transected, a razor blade was gently pressed 
across the esophagus approximately 25% of the length caudal to the pharynx.  
Disruption of muscular continuity was determined by loss of propagation of 
peristalsis across the disrupted region and loss of fluorescent continuity along 
the muscularis externa.  Esophageal smooth muscle fluorescence (which 
provided an indirect measure of smooth muscle cellular differentiation) was 
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examined with a dissecting microscope coupled to a magnesium arc lamp and 
a GFP filter. 
To determine if striated myodifferentiation could be inhibited by a known 
inhibitor of myodifferentiation that acts through the MAP kinase pathway (basic 
fibroblast growth factor) (Tortorella et al., 2001), hrFGF-2 (233-FB, R&D 
systems, Minneapolis, MN), MEK inhibitor PD98059 (513000, Calbiochem, La 
Jolla, CA) (Tortorella et al., 2001), or both, were added to achieve final 
concentrations of 25 μg/ml hrFGF-2 and/or 50μM PD98059.  Fresh hrFGF-2 
and/or PD98059 were added every 12 hours, when media were exchanged.  
To determine if fetal esophageal peristalsis was regulated by interstitial cells of 
Cajal (ICC), esophagi were cultured as described above, but with 5μg/ml 
ACK2 antibody (Gibco BRL, Gaithersburg, MD), which is a neutralizing 
antibody directed against c-kit (which, in turn, is essential in maintaining ICC 
phenotype), added to the media, and exchanged every 12 hours (David et al., 
2005). 
Esophagi used for immunohistochemical analysis were fixed in the 
culture filters for 24 hours in 10% formalin, mounted in specimen processing 
gel (Histogel, Richard Allan Scientific, Kalamazoo, MI) and then embedded in 
paraffin and sectioned at 4μm. 
We performed each series of esophageal culture experiments at least 6 
times.  For baseline culture experiments, all fetuses in a litter were used (8-12 
fetuses/litter).  When performing experiments with hrFGF-2 and/or PD98059, 
litters were divided into 3 groups – control group, hrFGF-2 group and 
PD98059/hrFGF-2 group, with an average of 3 fetuses per group.  Thus each 
experimental condition was repeated on at least 18 fetuses. 
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composite digital images of esophagi that were obtained at identical 
magnifications.  Using a calibrated scale bar, we were able to estimate the 
total esophageal length and the percentage of the esophagus displaying 
striated myogenesis at each time point. 
Immunohistochemistry 
For myogenin immunostaining, fixed sections were steamed for 15 
minutes in 0.01M citrate buffer (pH 6.0), blocked in mouse IgG blocking 
reagent (M.O.M., Vector Labs, Burlingame, CA) for 1 hour with TBS triton, 
10% goat serum and 10% non-fat dry milk (NFDM) for 20 minutes, and 
incubated at 37ºC for 20 minutes and at room temperature for 40 minutes with 
mouse anti-rat myogenin (1:30, M3559, DakoCytomation Inc, Carpinteria, CA).  
Sections were then incubated with biotinylated anti-mouse (M.O.M., Vector 
Labs, Burlingame, CA) for 20 minutes at room temperature, followed by 
streptavidin-conjugated horse-radish peroxidase (Zymed Laboratories, San 
Francisco, CA) and visualized with AEC (Zymed Laboratories, San Francisco, 
CA). 
For smooth muscle α-actin immunostaining, fixed sections were 
blocked in mouse IgG blocking reagent as above and incubated at 37ºC for 20 
minutes and at room temperature for 40 minutes with mouse-antihuman anti-
smooth muscle α-actin (1:60, M0851, clone 1A4, Dakocytomation Inc, 
Carpintaria, CA).  Secondary antibody staining was as above. 
To determine ACK2 antibody penetration into cultured organs, fixed 
slides were blocked for 20 minutes with 10% goat serum (Zymed Laboratories, 
San Francisco, CA) and incubated with biotinylated goat anti-rat IgG (Jackson 
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Immunoresearch Labs, Westgrove PA) for 20 minutes at room temperature, 
followed by Texas-Red Avidin DCS (Vector Labs, Burlingame CA). 
Positive and negative controls were performed with each 
immunohistochemical experiment, using either smooth muscle tissue for anti-
smooth muscle α-actin or ACK2 antibodies and replacing these primary 
antibodies from the sections with mouse or rat IgG as a nonspecific negative 
control. 
Immunoblotting 
Esophagi cultured with FGF-2 and with FGF-2 plus PD98059 were 
disrupted by several freeze-thaw cycles in a radioimmunoprecipitation
 assay 
(RIPA) buffer containing 20 mM Tris-HCl (pH 8.0), 137
 mM NaCl, 10% 
glycerol, 1% Nonidet P-40, 0.1% sodium dodecyl
 sulfate (SDS), 0.5% 
deoxycholate, 2 mM EDTA, 5 mM sodium vanadate,
 0.2 mM 
phenylmethylsulfonyl fluoride, 5 mM benzamidine.  After
 centrifugation to 
remove cell debris, the protein concentrations in
 the whole-cell lysates were 
determined.  Proteins (30 µg) from individual samples were resolved
 by SDS-
PAGE and transferred to polyvinylidene difluoride membranes
 by 
electroblotting. The blots were blocked with 5% nonfat dry
 milk (NFDM) in 
TBST (10 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.05%
 Tween 20) and then 
probed with anti-phospho-ERK1/2 antibody (1:1000 dilution; Cell Signaling, 
Beverly MA) or anti-ERK antibody (1:500 dilution; Santa Cruz Biotechnology, 
Inc., Santa
 Cruz, CA). Species-specific secondary antibodies coupled to 
horseradish peroxidase (1:5000 dilution in 5%
 NFDM/TBST; Santa Cruz 
Biotechnology) were used to detect the primary antibodies. Protein bands 
91 were visualized
 using enhanced chemiluminescence (PerkinElmer, Boston, 
MA). 
 
Results 
Striated myogenesis occurs in fetal esophageal muscularis 
externa in culture.  Embryonic day 14.5 esophagi were explanted and 
immunostained for myogenin, a specific transcription factor involved in striated 
myogenesis, to examine the process of esophageal myogenesis.  Over the 7 
day period of examination, myogenin positive cells first appeared in the rostral 
esophagus, with myogenin expression progressing caudally along the length 
of the esophagus over the 7 day period (Figure 4.1).  Myogenin positive cells 
could be detected along approximately 25-30%, 50% and 70% of the 
esophagus after 3, 5 and 7 days of culture respectively, but not at culture day 
0, consistent with previous observations (Zhao and Dhoot 2000c).  We could 
not detect any myogenin-positive cells near the lower-esophageal sphincter, in 
the stomach or in any esophageal layer other than the muscularis externa at 
any time, but myogenin-positive cells were detected in the pharynx and lingual 
musculature as early as culture day 0 (Figure 4.1).  Myogenin expression 
appeared to progress slightly more rapidly in the external (longitudinal) layer of 
the muscularis externa than the internal layer.  No differences were apparent 
between wild-type and SMCG2
+/WT transgenic fetuses in any experiments, so 
results were pooled. 
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Figure 4.1  Sagittal sections of murine esophagi from ED14.5 fetuses 
show progressive myogenin expression over 7 days of culture.  Inset (a) 
shows myogenin expression (red nuclear staining) in the diaphragm; (b) 
shows myogenin expression in 3-4 subpharyngeal nuclei; (c) shows robust 
myogenin expression in the tongue; (d) shows myogenin expression extending 
caudally along the rostral muscularis externa layers; (e) shows myogenin 
expression in the muscularis externa approaching the stomach.  Scale bar for 
large panels = 500μm; scale bar for inset panels = 100μm. 
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muscle muscularis externa.  Our previous studies, and those of other 
investigators, have refuted the hypothesis that smooth muscle cells in the 
esophageal muscularis externa transdifferentiate into striated muscle cells 
(Zhao and Dhoot 2000a; Zhao and Dhoot 2000b; Zhao and Dhoot 2000c; 
Rishniw et al., 2003; Rishniw et al., 2007), however, the origin of the striated 
muscle cells remains unknown.  Recently, investigators have suggested that 
esophageal striated muscle cells arise from a resident population of precursor 
cells (Wörl and Neuhuber 2005).  However, that study did not rule out the 
possibility that these striated muscle precursor cells actively migrate into the 
smooth muscle layers from a subpharyngeal location.  To examine this 
hypothesis, we partially or completely transected fetal esophagi at harvest 
(ED14.5) just caudal to the larynx/pharynx.  In partially transected esophagi 
the serosal and mucosal layers remained intact, but the muscularis externa 
was completely separated (Figure 4.2A), as demonstrated by an interruption of 
fluorescence of the smooth muscle layers (Figure 4.2B) and a failure of 
propagation of peristaltic waves through this zone (Supplemental data video 
1).  If muscle cell precursors migrate caudally to their locations in the 
muscularis externa during development, we would expect to observe a lack of 
myogenin staining caudal to the partially transected zone, because the 
migratory path would be disrupted.   
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Figure 4.2  Mechanical disruption of the esophageal muscularis externa 
results in discontinuity of smooth muscle fluorescence. (A) Fresh whole 
mount ED14.5 esophagus explanted from SMCG2 transgenic mice (which 
express eGFP in smooth muscle) showing 3 adjacent zones of muscularis 
externa disruption (arrows). (B) Fluorescent imaging shows loss of smooth 
muscle fluorescence through the disrupted zones (arrows). 
 
However, we found robust myogenin expression in the caudal 
esophageal segment at culture day 7 (Figure 4.3A), indicating that striated 
muscle precursors are already resident within the developing muscularis 
externa at ED14.5.  On the other hand, in completely transected esophagi, 
where there was no serosal continuity (and therefore no proximity of the rostral 
and caudal esophageal segments), we could not detect striated myogenesis in 
95 the caudal esophageal segment, despite continued robust peristalsis of both 
segments, and myogenin expression in the proximal segment (Figure 4.3B).   
 
 
Figure 4.3  Striated myogenesis occurs in esophagi with mechanically 
disrupted muscularis externa. (A) Sagittal section of ED14.5 esophagus 
with a disrupted muscularis externa (arrow) but contiguity of the rostral and 
caudal segments after 7 days of culture shows myogenin expression on both 
sides of the zone of disruption (inset panels).  The apparent dissociation to the 
right of the arrow (rostral) is a sectioning artifact, where a section of 
esophagus was positioned outside of the sectioning plane. (B) Myogenin 
expression is visible only in the subpharyngeal segment in a completely 
transected E14.5 esophagus after 7 days of culture, but is absent in the 
caudal segment (inset panels). Scale bar for large panels = 500μm; scale bar 
for inset panels = 100μm. 
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Together, these findings suggest that myogenic precursors do not 
migrate from the pharyngeal musculature at the time of myodifferentiation, but 
are resident in the proximal esophagus.  Moreover, these results suggest that 
local factors are responsible for the activation of resident precursor cells, as 
segments that maintain close proximity show evidence of a progressive 
myodifferentiation.  During striated myogenesis the smooth muscle component 
of the esophagus remains essentially unaltered, and remains considerably 
larger than the striated muscle cell component. 
Fetal esophagi remain functional and viable for up to 7 days in 
culture.  Esophageal explants maintained a functional phenotype for up to 7 
days in culture.  They failed to grow (length and width remained unchanged), 
but demonstrated vigorous spontaneous peristalsis throughout this period.  
Peristaltic waves occurred approximately every 20-30 seconds when 
examined at room temperature on an inverted dissecting scope, and 
propagated rostrally and caudally.  Some of these waves were coordinated 
with gastric contractions, but not every gastric contraction propagated a 
retrograde peristaltic wave (Supplemental data video 2).  Histologically, 
Smooth muscle α-actin could be identified in 3 distinct muscle layers along the 
length of the esophagus, corresponding to the 2 layers of the muscularis 
externa and the inner layer of the muscularis mucosae (Figure 4.4A), 
indicating that the smooth muscle cells maintained their phenotype throughout 
this period. 
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Figure 4.4 Smooth muscle maintains smooth muscle actin expression in 
culture for 7 days, but is attenuated by FGF-2. (A) Sagittal section of 
ED14.5 esophagus after 7 days of culture shows robust expression of smooth 
muscle actin in all 3 smooth muscle layers of the esophagus. (B) Smooth 
muscle actin expression is attenuated after 7 days of culture when FGF-2 is 
added to the culture media.  Note the loss of actin in the outer gastric muscle 
layers. (C)  Myogenin expression remains unaffected by culture in FGF-2. 
Scale bar = 500μm  Inset: PD98059 inhibits ERK1/2 phosphorylation by FGF-
2.  ED14.5 esophageal lysates, immunoblotted with anti-phospho ERK1/2 or 
anti-pan-ERK antibodies, show complete inhibition of ERK1/2 phosphorylation 
by FGF-2 after concurrent treatment with MEK inhibitor PD98059 (upper 
panel, lanes 3 and 4).  Esophagi treated with FGF-2 alone show robust 
phosphorylation of ERK1 and ERK2 (upper panel, lanes 1 and 2).  Total ERK 
expression is similar for all samples (lower panel). 
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Esophageal striated myogenesis is not fibroblast growth factor 
dependent.  Striated myogenesis is modulated by fibroblast growth factor 2 
(FGF-2), which inhibits the expression of the differentiation markers MyoD and 
myogenin (Weyman and Wolfman 1998; Jones et al., 2001; Tortorella et al., 
2001).  Similarly, SMCs cultured in FGF-2 undergo de-differentiation or fail to 
express smooth muscle cell contractile proteins (Thyberg 1996; Kato et al., 
1998; Kawai-Kowase et al., 2004).  To determine if esophageal striated 
myogenesis was modulated through an FGF-2 dependent pathway, 
esophageal explants were cultured in 25μg/ml hrFGF-2 for 7 days.  Under 
these conditions spontaneous peristalsis was markedly diminished over the 
culture period.  A decrease in both frequency and amplitude of peristaltic 
waves was first observed after 3 days of culture, with FGF-2 treated esophagi 
contracting every 45-60 seconds, compared to control esophagi that 
contracted every 20-30 seconds.  Inhibition of MEK with PD98059 prevented 
this attenuation of contractility. 
Histologically, smooth muscle α-actin expression decreased in the 
muscularis externa after 7 days of culture in FGF-2 augmented media (Figure 
4.4B), consistent with the observed loss of function.  Inhibition of MEK with 
PD98059 resulted in attenuated phospho-ERK1/2 expression (Figure 4.4A 
inset) and prevented the decrease in smooth muscle α-actin expression, 
consistent with previous observations.  (Kawai-Kowase et al., 2004)  However, 
striated myogenesis continued in the presence of FGF-2, with little or no 
attenuation of myogenin expression (Figure 4.4C).  These findings suggest 
that myogenin expression may not be FGF-2 dependent in the esophagus or 
in vivo and may be a phenomenon observed only in cell culture.  This is 
consistent with observations that mice overexpressing FGF-2 develop normal 
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unable to interact with FGF receptors (Coffin et al., 1995). 
c-kit-neutralizing antibody, ACK2, fails to inhibit peristalsis in 
cultured fetal esophagi.  To determine if the peristalsis was induced by c-kit-
positive interstitial cells of Cajal (ICC), we immunostained esophageal and 
gastric sections from ED14.5 uncultured fetuses with an anti-CD117 antibody.  
We could detect occasional immunopositive cells within the esophageal and 
gastric muscularis externa.  Based on previous studies that documented 
inhibition of peristalsis in cultured fetal ureters after c-kit blockade (David et al., 
20050, we cultured fetal esophagi in media containing 5μg/ml ACK-2 c-kit-
neutralizing antibody.  This failed to inhibit peristalsis over the 7 day culture 
period, despite strong penetration of the antibody into the muscularis externa 
(Figure 4.5), indicating that spontaneous peristalsis within the fetal esophagus 
is not ICC-dependent. 
 
 
Figure 4.5  ACK2 antibody penetrates esophagi in culture but fails 
to inhibit peristalsis.  Sagittal section of ED14.5 esophagus labeled with a 
biotinylated goat anti-rat antibody and detected with Texas Red avidin.  
Fluorescence can be detected throughout the esophagus, indicating complete 
penetration of the antibody during the culture period. 
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Discussion 
We have provided additional evidence that esophageal striated 
myogenesis occurs from a resident population of myogenic precursors and 
that the striated myogenic program may be resistant to FGF-2 inhibition.  
While we could not determine the early embryonic origin of esophageal 
striated muscle cells, our data support recently published studies showing 
resident myogenic precursors (Wörl and Neuhuber 2005) and suggest that the 
progression of myogenesis depends on local factors.  Additionally, we have, 
for the first time, cultured fetal murine esophageal explants, and maintained a 
functional phenotype for 7 days.  The contractile behavior of explanted 
esophagi appears to be independent of ICCs. 
Myogenin expression proceeded ex vivo in a rostro-caudal direction 
(from pharynx to stomach), consistent with previous observations that striated 
myogenesis is initially detected in the subpharyngeal regions and proceeds 
caudally along the length of the esophagus (Zhao and Dhoot 2000a; Zhao and 
Dhoot 2000b).  Expression of myogenin at day ED14.5 was absent in any part 
of the esophagus, but progressed rostro-caudally over the 7 days in culture, 
similar to previous observations (Zhao and Dhoot 2000c).  Similarly, the 
finding that myogenic precursors exist along 70% of the length of the 
esophagus by day ED14.5 is consistent with previous observations that Myf5 
and MyoD expression was observable along most of the esophagus by this 
stage of development (Zhao and Dhoot 2000a)  Our study demonstrates that 
these precursors did not migrate from a subpharyngeal location to the distal 
esophagus, but were resident in that tissue by day ED14.5.  Had these 
precursors migrated from the subpharyngeal region along a smooth muscle 
lattice, mechanical disruption of the lattice should have prevented myogenin 
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expression in partially disrupted esophagi, indicating that myogenic precursors 
were present in the distal esophagus prior to mechanical disruption.  We 
cannot, however, rule out the possibility that these precursor cells migrate 
through the esophagus prior to ED14.5.  On the other hand, complete 
separation of the esophagi into 2 independent segments resulted in failure of 
myogenin expression in the distal (pre-gastric) segment, suggesting that either 
humoral or mechanical factors are involved in propagating a wave of myogenic 
activation and myodifferentiation. Additionally, we cannot conclude that the 
myodifferentiation observed ex vivo precisely mirrors events that occur in vivo.  
For example, cultured fetal esophagi failed to elongate appreciably over the 7 
day culture period, whereas our previous studies of esophageal development 
in vivo demonstrate that the esophagus grows in length during the last week of 
gestation (Rishniw et al., 2007).  It is likely that mechanical factors (distraction 
of the esophagus by a growing thorax), which are absent in our culture model, 
contribute to the normal development of the esophagus. 
The persistence of esophageal peristalsis in the presence of the c-kit 
neutralizing antibody, ACK2, differs from the results obtained with fetal ureteral 
explants, where peristalsis was abolished within a few days of culture (David 
et al., 2005).  While we identified occasional c-kit positive cells in ED14.5 
esophagi, and ACK2 penetration into tissues appeared sufficient to inhibit c-kit 
receptors, peristalsis remained unaffected.  This suggests that peristalsis is 
propagated in explanted esophagi by spontaneous smooth muscle 
depolarizations, rather than ICCs. 
Peristalsis occurred both antegrade and retrograde in explanted 
esophagi.  Peristalsis in adults is predominantly antegrade, but retrograde 
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peristalsis can occur (eructation and regurgitation in ruminants and birds).  
The direction of peristalsis is dependent, in part, on the site of initiation – in 
adults, swallowing initiates antegrade peristalsis.  In our fetal culture 
experiments, gastric peristalsis appeared to trigger many of the retrograde 
peristaltic waves.  Whether this occurred because of a continuity of electrical 
coupling between the stomach and esophagus, that later disappears, or due to 
mechanical initiation of a peristaltic wave (stretch-induced depolarization of 
esophageal muscle), is not known.  Furthermore, whether bidirectional 
peristaltic activity occurs in utero in mice is unknown. 
The failure of FGF-2 to inhibit myogenin expression was unanticipated.  
An effect of FGF-2 was observed, namely, a dedifferentiation of smooth 
muscle cells (characterized by loss of smooth muscle actin) and a concomitant 
attenuation of spontaneous contractile function, indicating that FGF-2 
concentrations in the media were sufficient to produce a physiological effect.  
However, myogenin expression continued unabated in the presence of FGF-2, 
suggesting that in this system, striated myogenesis is not completely inhibited 
by FGF-2. 
In conclusion, we have developed an ex vivo fetal esophageal culture 
model that remains functional for at least 7 days.  Striated myogenesis in this 
model proceeds with a rostro-caudal activation of resident myogenic precursor 
cells that are resistant to FGF-2 inhibition of differentiation, but are dependent 
on structural integrity of the esophagus. 
 
Acknowledgments 
This study was supported in part by NIH grant RO1 DK065992 
(Kotlikoff), NIH training grant T32RR07059-09 (Rishniw) 
103 REFERENCES 
 
Coffin, J.D., R.Z. Florkiewicz, J. Neumann, T. Mort-Hopkins, G.W. Dorn 2nd, 
P. Lightfoot, R. German, P.N. Howles, A. Kier, B.A. O'Toole (1995) 
Abnormal bone growth and selective translational regulation in basic 
fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6:1861-
1873 
David, S.G., C. Cebrian, E.D. Vaughan Jr, D. Herzlinger (2005) c-kit and 
ureteral peristalsis. J Urol 173:292-295 
Jones, N.C., Y.V. Fedorov, R.S. Rosenthal, B.B. Olwin (2001) ERK1/2 is 
required for myoblast proliferation but is dispensable for muscle gene 
expression and cell fusion. J Cell Physiol 186:104-115 
Kablar, B., S. Tajbakhsh, M.A. Rudnicki (2000) Transdifferentiation of 
esophageal smooth to skeletal muscle is myogenic bHLH factor-
dependent. Development 127:1627-1639 
Kato, S., A. Muraishi, T. Miyamoto, J.C. Fox (1998) Basic fibroblast growth 
factor regulates extracellular matrix and contractile protein expression 
independent of proliferation in vascular smooth muscle cells. In Vitro 
Cell Dev Biol Anim 34:341-346 
Kawai-Kowase, K., H. Sato, Y. Oyama, H. Kanai, M. Sato, H. Doi, M. 
Kurabayashi (2004) Basic fibroblast growth factor antagonizes 
transforming growth factor-beta1-induced smooth muscle gene 
expression through extracellular signal-regulated kinase 1/2 signaling 
pathway activation. Arterioscler Thromb Vasc Biol 24:1384-1390 
104  
Patapoutian, A., B.J. Wold, R.A. Wagner (1995) Evidence for developmentally 
programmed transdifferentiation in mouse esophageal muscle. Science 
270:1818-1821 
Rishniw, M., H.B. Xin, K.Y. Deng, M.I. Kotlikoff (2003) Skeletal myogenesis in 
the mouse esophagus does not occur through transdifferentiation. 
Genesis 36:81-82 
Rishniw, M., P.W. Fisher, R.M. Doran, E. Meadows, W.H. Klein, M.I. Kotlikoff 
(2007) Smooth muscle persists in the muscularis externa of developing 
and adult mouse esophagus. J Muscle Res Cell Motil 28:153-165 
Stratton, C.J., Y. Bayguinov, K.M. Sanders, S.M. Ward (2000) Ultrastructural 
analysis of the transdifferentiation of smooth muscle to skeletal muscle 
in the murine esophagus. Cell Tissue Res 301:283-298 
Thyberg, J. (1996) Differentiated properties and proliferation of arterial smooth 
muscle cells in culture. Int Rev Cytol 169:183-265 
Tortorella, L.L., D.J. Milasincic, P.F. Pilch (2001) Critical proliferation-
independent window for basic fibroblast growth factor repression of 
myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem 
276:13709-13717 
Weyman, C.M., A. Wolfman (1998) Mitogen-activated protein kinase kinase 
(MEK) activity is required for inhibition of skeletal muscle differentiation 
by insulin-like growth factor 1 or fibroblast growth factor 2. 
Endocrinology 139:1794-1800 
Wörl, J., W.L. Neuhuber (2005) Ultrastructural analysis of the smooth-to-
striated transition zone in the developing mouse esophagus: Emphasis 
on apoptosis of smooth and origin and differentiation of striated muscle 
cells. Dev Dyn 233:964-982 
105 Zhao, W., G.K. Dhoot (2000a) Both smooth and skeletal muscle precursors 
are present in foetal mouse oesophagus and they follow different 
differentiation pathways. Dev Dyn 218:587-602 
Zhao, W., G.K. Dhoot (2000b) Development and composition of skeletal 
muscle fibres in mouse oesophagus. J Muscle Res Cell Motil 21:463-
473 
Zhao, W., G.K. Dhoot (2000c) Skeletal muscle precursors in mouse 
esophagus are determined during early fetal development. 
Developmental Dynamics 219:10-20 
106 CHAPTER 5 
 
 
 
 
SUMMARY & FUTURE DIRECTIONS 
107 The preceding studies have focused on the development of the murine 
esophageal musculature.  Ever since the initial proposal by Patapoutian and 
colleagues in the mid-1990s that esophageal smooth muscle cells within the 
muscularis externa might transdifferentiate into striated muscles during 
perinatal esophageal development, several groups of investigators have tried 
to confirm or refute this hypothesis.  The subsequent interest in this initial 
observation lies not only in esophageal development per se, but rather, if 
accurate, would provide a model for cellular plasticity, that has far broader 
implications.  Committed or even differentiated cell lines would no longer 
necessarily be restricted to one phenotype, but could, with appropriate (and as 
yet undefined) stimuli, transform into other phenotypes.  Understanding this 
transdifferentiation process in a validated, easily manipulated model, such as 
murine esophageal musculature, would be paramount to investigating this 
process in other, more clinically relevant cell lines, such as cardiac cells, 
neurons etc. 
My studies demonstrated that transdifferentiation does not occur in 
murine esophageal smooth muscle.  Rather, esophageal smooth muscle cells 
remain true to their original phenotype while undergoing several terminal 
pathways: segregation within the striated musculature as “remnant” smooth 
muscle cells, compaction around the lower esophageal sphincter, and 
apoptosis.  In contrast, striated muscle cell development progresses 
craniocaudally, most likely from a resident population of striated muscle 
precursors – a process that can be observed in explanted esophageal whole-
organ cultures.  
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Esophageal smooth muscle does not transdifferentiate into striated 
muscle. 
I provided three independent levels of evidence refuting the original 
hypothesis of transdifferentiation.  In Chapter 2, I devised a simple fate-
mapping experiment, whereby any cell expressing smooth muscle myosin 
heavy chain at any point in that cell’s existence would “unlock” a constitutively 
expressed marker (LacZ).  Thus, if an esophageal striated muscle cell had 
previously expressed smooth muscle myosin heavy chain, the LacZ gene 
would be activated within that striated muscle cell, resulting in β-galactosidase 
staining regardless of that cell’s ultimate fate.  My results revealed an absence 
of β-galactodisase activity in esophageal striated muscles, indicating that 
these striated muscles had never activated the smooth muscle heavy chain 
promoter. 
In Chapter 3, I examined the possibility of smooth-to-striated muscle 
transdifferentiation by searching for co-expression of nuclear proteins in cells 
undergoing striated myodifferentiation.  Specifically, I searched for a smooth-
muscle restricted Cre recombinase in cells expressing the striated muscle 
transcription factor myogenin, but could find no evidence of co-expression of 
these 2 lineage-dependent proteins.  However, as I pointed out in that chapter, 
a temporally dissociated expression of each of these proteins could not be 
ruled out. 
Finally, in Chapter 4, I devised and conducted a further experiment that 
examined the possibility of transdifferentiation.  Using a recently constructed 
conditional myogenin knockout mouse, I deleted the myogenin gene in smooth 
muscle cells by crossing this mouse with a mouse that expressed Cre 
recombinase in smooth muscle.  Since myogenin is absolutely required for 
109 striated muscle differentiation, smooth muscle cells lacking the myogenin gene 
that were undergoing transdifferentiation into striated muscles would fail to 
complete the differentiation process, resulting in esophageal myodysplasia.  
However, we observed normal esophageal development despite successful 
deletion of the myogenin gene in smooth muscle. 
Taken together, my results convincingly demonstrate that esophageal 
myogenesis does not involve transdifferentiation. 
 
Esophageal smooth muscle has variable fates 
One quandary for investigators examining esophageal myogenesis has 
been the fate of smooth muscle cells, where an organ that is initially 
composed entirely of smooth muscle develops into an organ with virtually no 
smooth muscle.  Substantial apoptosis was not detected by Patapoutian, 
although subsequent investigators suggested that apoptosis may occur more 
frequently than initially proposed. 
In Chapter 3, I examined the potential fate of esophageal smooth 
muscle cells, after a serendipitous observation, where I had noted linear 
fluorescence in the rostral esophagus of adult mice that expressed eGFP in 
smooth muscle.  Detailed investigation of this observation led me to conclude 
that the adult murine esophagus, which is almost exclusively composed of 
striated muscle, harbors what I termed “remnant” smooth muscle cells amidst 
the striated stroma.  These remnant cells are misshapen, express smooth 
muscle-specific proteins, and serve an as yet unknown function.  Their 
frequent proximity to interstitial cells of Cajal within the striated muscle layers 
suggests that they may be involved in maintaining integrity of the esophageal 
pacemaker cells.  Additionally, I demonstrated that the absolute length of the 
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smooth muscle component remains virtually unchanged during a 3-fold 
increase in esophageal length, suggesting that apoptosis is unlikely to be 
occurring over this period.  Finally, staining for apoptotic nuclei revealed a 
discrete population of cells undergoing apoptosis, however, this was a 
relatively infrequent event. 
Thus, I have provided a biologically plausible and simple explanation for 
the fate of smooth muscle cells in the esophageal muscularis externa, without 
the need to invoke a complex process such as transdifferentiation. 
 
Esophageal striated muscle development progresses ex vivo. 
In Chapter 4 I examined esophageal striated myogenesis in an isolated 
system.  I successfully cultured fetal esophagi for up to 7 days, during which 
time they retained a functional phenotype.  Serial examination of the myogenic 
development in explanted esophagi confirmed a cranio-caudal appearance of 
myoblasts, as defined by myogenin expression.  Partial mechanical disruption 
of esophageal integrity rostrally at the time of harvesting the esophagi did not 
alter the myogenic pattern over the following 7 days suggesting that the 
striated muscle precursors reside within the smooth muscle layer and are 
sequentially induced to myodifferentiate.  Complete disruption arrested 
myodifferentiation in the caudal esophageal segment, suggesting that either 
structural integrity is required to induce myodifferentiation, or a paracrine 
factor is involved and is prevented from passing in a cranio-caudal direction 
when the esophagus is divided into 2 separate segments. 
Finally, I showed that fetal esophageal peristaltic function is not 
dependent on interstitial cells of Cajal, which have been shown to induce 
peristaltic activity in other developing organs. 
111 Future Directions 
Despite having resolved the issue of transdifferentiation as a 
mechanism for esophageal myogenesis in the mouse, many questions remain 
unanswered.  Most striated muscle in the body arises from somites, with 
striated muscle precursors migrating in several waves to their final location.  
An exception to this are branchiomeric (head) and certain extra-ocular 
muscles, which have been shown to arise from separate precursor 
populations.  Lingual and pharyngeal muscles, however, are not included in 
this group, but have been shown to have a somitic origin. 
Where do the striated muscle precursors that populate the esophageal 
muscularis externa originate?  One possibility is that they migrate along with 
the somitic precursors that populate the pharynx to the developing throat, and 
are seeded from these cells as the esophageal primitive tube develops and 
elongates, lying dormant until they are induced to myodifferentiate.  This 
process has been documented for the extrinsic laryngeal muscles.  Relatively 
simple experiments could potentially answer whether esophageal striated 
muscle precursors are derived from this population.   
As detailed in the introductory chapter, several genes are expressed 
exclusively in one embryonic muscular precursor population or another.  For 
example, somitically derived striated muscle precursors express Paraxis, 
Lbx1, Pax3, and MRF4, whereas head and pharyngeal muscle precursors 
generally do not.  Conversely, most head muscles, which originate from the 
cranial paraxial mesoderm, exclusively express Tbx1, Tcf21, FGF10 and Tlx1. 
Conditional null mice and reporter mice exist for several of these genes.  
For example Pax3 null mice exist as a spontaneous mutation (Splotch mice), 
and have also been created de novo by targeted deletion of Pax3.  
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Examination of esophageal muscularis externa in Pax3 null mice at birth 
should reveal whether striated myogenesis is affected.  If unaffected, this 
would suggest that myogenesis is independent of Pax3, and therefore unlikely 
to be of somitic origin.  Similarly, a Tbx1-Cre reporter mouse exists.  Since 
Tbx1 is required for striated myogenesis of muscles derived from branchial 
(pharyngeal) arches, and is not expressed in somitically derived muscles, 
simple examination of Tbx1-Cre::R26R mice at 2 weeks after birth would 
determine if esophageal striated muscle expresses b-galactosidase, 
confirming that this muscle is branchiomeric.  A complimentary experiment, 
involving examining a Tbx1
-/- mouse after birth would help confirm whether 
Tbx1 is essential for esophageal myogenesis. 
A recent study demonstrated that Myf5
-/-::MyoD
-/- mice with a functional 
Myf6 (MRF4) gene failed to develop head muscles or limb muscles, but 
developed epaxial and hypaxial muscles.  Examination of these mice for 
esophageal development at birth could help support the hypothesis that 
esophageal muscle precursors are or are not dependent on Myf6 (MRF4) 
expression.  Previous studies have shown Myf6 (MRF4) expression in 
developing esophagus, but this may be through the classical downstream 
activation by Myf5/MyoD pathway. 
There are at least 2 transcription factors expressed exclusively in the 
somites and somitically derived cells (and the pre-otic paraxial mesoderm that 
gives rise to the lateral rectus muscle) during early fetal development: Paraxis 
and Lbx1.  By constructing a Paraxis promoter-driven Cre recombinase 
transgene, and using the R26R reporter mouse (that constitutively expresses 
LacZ in tissues that co-express, even transiently, Cre recombinase), it should 
be possible to fate map all cells that express Paraxis.  Subsequently, staining 
113 the esophageal striated muscle for β–galactosidase activity would determine if 
these cells are of somitic origin (with the exception of the lateral rectus).  
Similar experiments could be conducted using the Lbx1 promoter, which is 
activated in migrating striated muscle precursors of somitic origin.  An 
alternative approach, using available genetically modified mice, would involve 
examining the Lbx1
GFP mouse, which expresses GFP under control of the 
Lbx1 promoter (this mouse was developed through a “knock-in” strategy).  
Examining Lbx1
GFP/+ heterozygotes would permit “tracking” of cells expressing 
Lbx1 to the pharynx/tongue region and, if present, in the esophagus.  
Alternatively, Lbx1
GFP/GFP mice would fail to express Lbx1, allowing 
examination of esophageal myogenesis in the absence of Lbx1. 
A further peculiarity about esophageal striated myogenesis remains – 
the myogenic program in this organ is implemented considerably later than 
other striated myogenic programs.  By the time the myogenic precursors begin 
to express early myogenic regulatory factors in the mouse (embryonic day 11-
12), the tongue and pharynx are thoroughly populated with myoblasts and 
myocytes, as are limbs and torso.  Secondary and tertiary waves of 
myogenesis occur in other tissues, but nothing is known about such events in 
the esophagus.  The cues that drive these additional myogenic waves are not 
well defined.  Esophageal myogenesis could serve as a model for the delayed 
myogenic programs that occur throughout the body.  Regional genomic 
analysis of esophageal tissue at various stages of myogenesis could allow 
factors to be identified that instigate myodifferentiation along the developing 
esophagus.  Using the ex vivo culture model I developed, conditions could be 
controlled to allow gene expression profiling at different timepoints in an 
attempt to elucidate myogenic triggers.  For example, esophageal myogenic 
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precursors could be examined for expression of Pax3 and Pax7, which are 
characteristically expressed by satellite cells, and myogenic progenitor cells 
involved in the third phase of myogenesis. 
A final teleological issue is that of the interspecies variability of 
esophageal anatomy – why are their multiple designs for a tube that connects 
the pharynx and the stomach, and propels food or fluid boluses predominantly 
in one direction?  In humans, the esophagus remains almost exclusively a 
smooth muscle organ, in mice and ruminants it is almost exclusively striated in 
nature, while other species have variable contributions of each muscle type.  
There does not appear to be any rhyme-nor-reason to this variation in 
anatomy, since esophageal function between species is not markedly 
different.  Does the extent of striated myogenesis simply reflect the time in 
fetal development at which striated muscle precursors migrate to the rostral 
esophago-pharyngeal junction?  Assuming that esophageal striated muscle 
precursors “seed” from this rostral location as the smooth muscle esophagus 
develops, the extent of this “seeding” would depend on the degree of 
esophageal development at the time of arrival of precursor cells.  Once the 
origin of these cells is identified in the mouse, it could be feasible to examine 
this hypothesis in other species by comparing the earliest detectable 
precursors and the level of esophageal development at the time of detection. 
Despite marked advances in understanding myogenesis in mammals, 
both through the body, and in the head, esophageal myogenesis remains 
poorly understood, and, to some extent, ignored by physiologists investigating 
these processes.  However, better understanding of this unique myogenic 
process could allow better understanding of muscle formation elsewhere in the 
body. 
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